商务合作
动脉网APP
可切换为仅中文
AbstractOver the last decades, the role of neuroinflammation in neuropsychiatric conditions has attracted an exponentially growing interest. A key driver for this trend was the ability to image brain inflammation in vivo using PET radioligands targeting the Translocator Protein 18 kDa (TSPO), which is known to be expressed in activated microglia and astrocytes upon inflammatory events as well as constitutively in endothelial cells.
摘要在过去的几十年中,神经炎症在神经精神疾病中的作用引起了人们越来越多的兴趣。这种趋势的一个关键驱动因素是使用靶向易位蛋白18 kDa(TSPO)的PET放射性配体在体内成像脑部炎症的能力,已知其在炎症事件以及内皮细胞中组成性地在活化的小胶质细胞和星形胶质细胞中表达。
TSPO is a mitochondrial protein that is expressed mostly by microglial cells upon activation but is also expressed by astrocytes in some conditions and constitutively by endothelial cells. Therefore, our current understanding of neuroinflammation dynamics is hampered by the lack of alternative targets available for PET imaging.
TSPO是一种线粒体蛋白,在激活后主要由小胶质细胞表达,但在某些条件下也由星形胶质细胞表达,并由内皮细胞组成。因此,由于缺乏可用于PET成像的替代靶标,我们目前对神经炎症动力学的理解受到阻碍。
We performed a systematic search and review on radiotracers developed for neuroinflammation PET imaging apart from TSPO. The following targets of interest were identified through literature screening (including previous narrative reviews): P2Y12R, P2X7R, CSF1R, COX (microglial targets), MAO-B, I2BS (astrocytic targets), CB2R & S1PRs (not specific of a single cell type).
我们对除TSPO外为神经炎症PET成像开发的放射性示踪剂进行了系统的搜索和综述。通过文献筛选(包括以前的叙述性评论)确定了以下感兴趣的靶标:P2Y12R,P2X7R,CSF1R,COX(小胶质细胞靶标),MAO-B,I2BS(星形胶质细胞靶标),CB2R和S1PR(非特定于单细胞类型)。
We determined the level of development and provided a scoping review for each target. Strikingly, astrocytic biomarker MAO-B has progressed in clinical investigations the furthest, while few radiotracers (notably targeting S1P1Rs, CSF1R) are being implemented in clinical investigations. Other targets such as CB2R and P2X7R have proven disappointing in clinical studies (e.g.
我们确定了发展水平,并为每个目标提供了范围审查。引人注目的是,星形胶质细胞生物标志物MAO-B在临床研究中进展最快,而在临床研究中很少使用放射性示踪剂(特别是靶向S1P1R,CSF1R)。其他目标如CB2R和P2X7R在临床研究中已被证明令人失望(例如。
poor signal, lack of changes in disease conditions, etc.). While astrocytic targets are promising, development of new biomarkers and tracers specific for microglial activation has proven challenging..
信号不佳,疾病状况没有变化等)。虽然星形胶质细胞靶标很有希望,但开发针对小胶质细胞激活的新生物标志物和示踪剂已被证明具有挑战性。。
Access through your institution
Buy or subscribe
购买或订阅
This is a preview of subscription content, access via your institution
这是订阅内容的预览,可通过您的机构访问
Access options
访问选项
Access through your institution
通过您的机构访问
Access through your institution
通过您的机构访问
Change institution
变革机构
Buy or subscribe
购买或订阅
Subscribe to this journalReceive 12 print issues and online access251,40 € per yearonly 20,95 € per issueLearn moreBuy this articlePurchase on Springer LinkInstant access to full article PDFBuy nowPrices may be subject to local taxes which are calculated during checkout
订阅本期刊每年可收到12期印刷版和在线访问251,40欧元每期仅20,95欧元了解更多购买本文在Springer Link上购买即时访问全文PDFBuy NOW价格可能需要缴纳结帐时计算的当地税费
Additional access options:
其他访问选项:
Log in
登录
Learn about institutional subscriptions
了解机构订阅
Read our FAQs
阅读我们的常见问题
Contact customer support
联系客户支持
Fig. 1: Development stages of radiotracers for the currently explored microglial targets.Fig. 2: Development stages of radiotracers for the currently explored astrocytic targets.Fig. 3: Development stage of radiotracers for CB2R and S1PRs targets.
。图2:目前探索的星形胶质细胞靶标的放射性示踪剂的发展阶段。图3:CB2R和S1PRs靶标放射性示踪剂的发展阶段。
ReferencesJones HB. Some instances of the contrast between delirium tremens and inflammation of the brain, as regards the quantity of phosphoric acid excreted by the kidneys. Med Chir Trans. 1847;30:21–38.Article
参考琼斯HB。就肾脏排泄的磷酸量而言,震颤性谵妄与脑部炎症之间存在对比的一些例子。医学Chir Trans。1847年;30:21–38.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Gomez-Nicola D, Perry VH. Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity. Neuroscientist. 2015;21:169–84.Article
Gomez-Nicola D,Perry VH。小胶质细胞动力学和在健康和患病大脑中的作用:功能可塑性的范例。神经科学家。2015年;21:169–84.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2:734–44.Article
Allan SM,新泽西州罗思韦尔。细胞因子和急性神经变性。Nat Rev Neurosci。2001年;2: 734-44.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Benavides J, Quarteronet D, Imbault F, Malgouris C, Uzan A, Renault C, et al. Labelling of “peripheral-type” benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J Neurochem. 1983;41:1744–50.Article .
Benavides J,Quarteronet D,Imbault F,Malgouris C,Uzan A,Renault C等。使用异喹啉甲酰胺衍生物[3H]PK 11195标记大鼠脑中“外周型”苯二氮卓结合位点:动力学研究和放射自显影定位。神经化学杂志。1983年;41:1744-50。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Le Fur G, Vaucher N, Perrier ML, Flamier A, Benavides J, Renault C, et al. Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci. 1983;33:449–57.Article
Le Fur G,Vaucher N,Perrier ML,Flamier A,Benavides J,Renault C等。通过热力学研究区分外周苯二氮卓结合位点,[3H]RO5-4864和[3H]PK 11195的两种配体。生命科学。1983年;33:449–57.文章
PubMed
PubMed
Google Scholar
谷歌学者
Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402–9.Article
Papadopoulos V,Baraldi M,Guilarte TR,Knudsen TB,Lacapere JJ,Lindemann P等。易位蛋白(18kDa):基于其结构和分子功能的外周型苯二氮卓受体的新命名法。趋势药理学。2006年;27:402–9.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Banati RB. Visualising microglial activation in vivo. Glia. 2002;40:206–17.Article
巴纳蒂RB。可视化体内小胶质细胞活化。。2002年;40:206–17.文章
PubMed
PubMed
Google Scholar
谷歌学者
Owen DR, Matthews PM. Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands. Int Rev Neurobiol. 2011;101:19–39.Article
Owen DR,Matthews PM。使用正电子发射断层扫描和易位蛋白特异性放射性配体成像脑小胶质细胞活化。Int Rev Neurobiol。2011年;101:19–39.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Chauveau F, Boutin H, Van Camp N, Dolle F, Tavitian B. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging. 2008;35:2304–19.Article
Chauveau F,Boutin H,Van Camp N,Dolle F,Tavitian B.神经炎症的核成像:对[11C]PK11195挑战者的全面综述。Eur J Nucl Med Mol成像。2008年;35:2304–19.文章
PubMed
PubMed
Google Scholar
谷歌学者
Wimberley C, Buvat I, Boutin H. Imaging translocator protein expression with positron emission tomography. Eur J Nucl Med Mol Imaging. 2021;49:74–76.Article
Wimberley C,Buvat I,Boutin H.用正电子发射断层扫描成像易位蛋白表达。Eur J Nucl Med Mol成像。2021年;49:74–76.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Chauveau F, Becker G, Boutin H. Have (R)-[(11)C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies. Eur J Nucl Med Mol Imaging. 2021;49:201–20.Article
Chauveau F,Becker G,Boutin H.(R)-[(11)C]PK11195挑战者是否履行了承诺?临床TSPO PET研究的范围界定审查。Eur J Nucl Med Mol成像。2021年;49:201–20.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32:1–5.Article
Owen DR,Yeo AJ,Gunn RN,Song K,Wadsworth G,Lewis A等。18 kDa易位蛋白(TSPO)多态性解释了PET放射性配体PBR28结合亲和力的差异。。2012年;32:1–5.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC, et al. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med. 2011;52:24–32.Article
Owen DR,Gunn RN,Rabiner EA,Bennacef I,Fujita M,Kreisl WC等。人类与18 kDa易位蛋白配体的混合亲和结合。J Nucl Med。2011;52:24–32.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Tiwari AK, Ji B, Yui J, Fujinaga M, Yamasaki T, Xie L, et al. 18F]FEBMP: positron emission tomography imaging of TSPO in a model of neuroinflammation in rats, and in vitro autoradiograms of the human brain. Theranostics. 2015;5:961–9.Article
。治疗学。2015年;5: 961-9.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
MacAskill MG, Stadulyte A, Williams L, Morgan TEF, Sloan NL, Alcaide-Corral CJ, et al. Quantification of macrophage-driven inflammation during myocardial infarction with (18)F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism. J Nucl Med. 2021;62:536–44.Article .
MacAskill MG,Stadulyte A,Williams L,Morgan TEF,Sloan NL,Alcaide Corral CJ等。用(18)F-LW223定量心肌梗塞期间巨噬细胞驱动的炎症,F-LW223是一种新型TSPO放射性示踪剂,其结合独立于rs6971人类多态性。J Nucl Med。2021;。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Gui Y, Marks JD, Das S, Hyman BT, Serrano-Pozo A. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer’s disease brains. Brain Pathol. 2020;30:151–64.Article
Gui Y,Marks JD,Das S,Hyman BT,Serrano Pozo A.死后正常和阿尔茨海默病大脑中18 kDa易位蛋白(TSPO)表达的表征。大脑病理学。2020年;30:151–64.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Rizzo G, Veronese M, Tonietto M, Bodini B, Stankoff B, Wimberley C, et al. Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities. J Cereb Blood Flow Metab. 2019;39:874–85.Article
Rizzo G,Veronese M,Tonietto M,Bodini B,Stankoff B,Wimberley C等。TSPO PET成像内皮模型的推广:示踪剂亲和力的考虑。。;39:874–85.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Wimberley C, Lavisse S, Brulon V, Peyronneau MA, Leroy C, Bodini B, et al. Impact of endothelial 18-kDa translocator protein on the quantification of (18)F-DPA-714. J Nucl Med. 2018;59:307–14.Article
Wimberley C,Lavisse S,Brulon V,Peyronneau MA,Leroy C,Bodini B等。内皮18 kDa易位蛋白对(18)F-DPA-714定量的影响。J Nucl Med。2018;59:307–14.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Veronese M, Reis Marques T, Bloomfield PS, Rizzo G, Singh N, Jones D, et al. Kinetic modelling of [(11)C]PBR28 for 18 kDa translocator protein PET data: a validation study of vascular modelling in the brain using XBD173 and tissue analysis. J Cereb Blood Flow Metab. 2018;38:1227–42.Article .
Veronese M,Reis Marques T,Bloomfield PS,Rizzo G,Singh N,Jones D等。18 kDa易位蛋白PET数据的[(11)C]PBR28动力学建模:使用XBD173和组织分析对大脑血管建模的验证研究。。2018年;38:1227-42。第条。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015;72:268–75.Article
Setiawan E,Wilson AA,Mizrahi R,Rusjan PM,Miler L,Rajkowska G等。易位蛋白密度(一种神经炎症标志物)在重度抑郁发作期间大脑中的作用。JAMA精神病学。2015年;72:268–75.文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Su L, Faluyi YO, Hong YT, Fryer TD, Mak E, Gabel S, et al. Neuroinflammatory and morphological changes in late-life depression: the NIMROD study. Br J Psychiatry. 2016;209:525–6.Article
Su L,Faluyi YO,Hong YT,Fryer TD,Mak E,Gabel S等。晚期抑郁症的神经炎症和形态学变化:NIMROD研究。Br J精神病学。2016年;209:525–6.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Holmes SE, Hinz R, Conen S, Gregory CJ, Matthews JC, Anton-Rodriguez JM, et al. Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study. Biol Psychiatry. 2018;83:61–69.Article
Holmes SE,Hinz R,Conen S,Gregory CJ,Matthews JC,Anton Rodriguez JM等。抑郁症患者前扣带回易位蛋白升高和自杀思维中炎症的作用:正电子发射断层扫描研究。生物精神病学。2018年;83:61–69.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Meyer JH, Cervenka S, Kim MJ, Kreisl WC, Henter ID, Innis RB. Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry. 2020;7:1064–74.Article
梅耶JH,塞文卡S,金MJ,克雷斯尔WC,亨特ID,因尼斯RB。精神疾病中的神经炎症:PET成像和有希望的新靶点。柳叶刀精神病学。2020年;7: 1064-74.条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry. 2008;64:820–2.Article
van Berckel BN,Bossong MG,Boellaard R,Kloet R,Schuitemaker A,Caspers E等。新近发作的精神分裂症中的小胶质细胞激活:定量(R)-[11C]PK11195正电子发射断层扫描研究。生物精神病学。2008年;64:820–2.文章
PubMed
PubMed
Google Scholar
谷歌学者
Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC. Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med. 2009;50:1801–7.Article
Doorduin J,de Vries EF,Willemsen AT,de Groot JC,Dierckx RA,Klein HC。精神分裂症相关精神病的神经炎症:PET研究。J Nucl Med。2009;50:1801–7.文章
PubMed
PubMed
Google Scholar
谷歌学者
Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR, et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study. Am J Psychiatry. 2016;173:44–52.Article
Bloomfield PS,Selvaraj S,Veronese M,Rizzo G,Bertoldo A,Owen DR等。精神病和精神分裂症超高风险人群的小胶质细胞活性:一项[(11)C]PBR28 PET脑成像研究。Am J精神病学。2016年;173:44-52.文章
PubMed
PubMed
Google Scholar
谷歌学者
Takano A, Arakawa R, Ito H, Tateno A, Takahashi H, Matsumoto R, et al. Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. The international journal of neuropsychopharmacology. 2010;13:943–50.Article
Takano A,Arakawa R,Ito H,Tateno A,Takahashi H,Matsumoto R等。慢性精神分裂症患者的外周苯二氮卓受体:用[11C]DAA1106进行的PET研究。国际神经精神药理学杂志。2010年;13: 943-50.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G, et al. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr Bull. 2015;41:85–93.Article
Kenk M,Selvanathan T,Rao N,Suridjan I,Rusjan P,Remington G等。精神分裂症中灰质和白质的神经炎症成像:用[18F]-FEPPA进行的体内PET研究。精神分裂症公牛。2015年;41:85–93.文章
PubMed
PubMed
Google Scholar
谷歌学者
Holmes SE, Hinz R, Drake RJ, Gregory CJ, Conen S, Matthews JC, et al. In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study. Mol Psychiatry. 2016;21:1672–9.Article
Holmes SE,Hinz R,Drake RJ,Gregory CJ,Conen S,Matthews JC等。无抗精神病药和药物治疗精神分裂症脑小胶质细胞活性的体内成像:一项[(11)C](R)-PK11195正电子发射断层扫描研究。摩尔精神病学。2016年;21:1672–9.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R, et al. In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. NPJ Schizophr. 2016;2:16031.Article
van der Doef TF,de Witte LD,Sutterland AL,Jobse E,Yaqub M,Boellaard R等。近期发作的精神病中18kDa易位蛋白的体内(R)-[(11)C]PK11195 PET成像。NPJ精神分裂症。2016年;2: 第16031条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Di Biase MA, Zalesky A, O’Keefe G, Laskaris L, Baune BT, Weickert CS, et al. PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia. Transl Psychiatry. 2017;7:e1225.Article
Di Biase MA,Zalesky A,O'Keefe G,Laskaris L,Baune BT,Weickert CS等。PET成像显示精神病超高风险个体中假定的小胶质细胞激活,最近被诊断出患有精神分裂症。Transl精神病学。2017年;7: e1225条款
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Hafizi S, Tseng HH, Rao N, Selvanathan T, Kenk M, Bazinet RP, et al. Imaging microglial activation in untreated first-episode psychosis: a PET study with [(18)F]FEPPA. Am J Psychiatry. 2017;174:118–24.Article
Hafizi S,Tseng HH,Rao N,Selvanathan T,Kenk M,Bazinet RP等。未经治疗的首发精神病中的小胶质细胞激活成像:使用[(18)F]FEPPA的PET研究。Am J精神病学。2017年;174:118–24.文章
PubMed
PubMed
Google Scholar
谷歌学者
Conen S, Gregory CJ, Hinz R, Smallman R, Corsi-Zuelli F, Deakin B, et al. Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis. Mol Psychiatry. 2021;26:5398–406.Article
Conen S,Gregory CJ,Hinz R,Smallman R,Corsi Zuelli F,Deakin B等。通过正电子发射断层扫描测量近期发作和确诊的精神分裂症患者的神经炎症:对免疫发病机制的影响。摩尔精神病学。2021年;26:5398–406.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Collste K, Plaven-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A, et al. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [(11)C]PBR28. Mol Psychiatry. 2017;22:850–6.Article
Collste K,Plaven-Sigray P,Fatouros-Bergman H,Victorsson P,Schain M,Forsberg A等人。使用PET和[(11)C]PBR28测量的未经药物治疗的首发精神病患者中神经胶质细胞标志物TSPO的水平较低。摩尔精神病学。2017年;22:850–6.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
De Picker LJ, Haarman BCM. Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker. Eur J Nucl Med Mol Imaging. 2021;49:164–73.Article
De Picker LJ,哈曼BCM。TSPO PET成像作为临床免疫精神病学生物标志物的适用性,潜力和局限性。Eur J Nucl Med Mol成像。2021年;49:164–73.文章
PubMed
PubMed
Google Scholar
谷歌学者
Iliopoulou SM, Tsartsalis S, Kaiser S, Millet P, Tournier BB. Dopamine and neuroinflammation in schizophrenia - interpreting the findings from translocator protein (18kDa) PET imaging. Neuropsychiatr Dis Treat. 2021;17:3345–57.Article
Iliopoulou SM,Tsartsalis S,Kaiser S,Millet P,Tournier BB。精神分裂症中的多巴胺和神经炎症-解释易位蛋白(18kDa)PET成像的发现。神经精神病治疗。2021年;17: 3345-57.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, et al. In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry. 2016;6:e777.Article
Coughlin JM,Wang Y,Ambinder EB,Ward RE,Minn I,Vranesic M等。新近发作的精神分裂症炎症反应的体内标志物:使用[(11)C]DPA-713 PET和CSF和血浆分析的联合研究。Transl精神病学。2016年;6: e777.条款
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Narayanaswami V, Dahl K, Bernard-Gauthier V, Josephson L, Cumming P, Vasdev N. Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: outlook beyond TSPO. Mol Imaging. 2018;17:1536012118792317.Article
Narayanaswami V,Dahl K,Bernard Gauthier V,Josephson L,Cumming P,Vasdev N.新兴PET放射性示踪剂和神经退行性疾病神经炎症成像靶点:TSPO以外的展望。摩尔成像。2018年;17: 1536012118792317条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Janssen B, Vugts DJ, Windhorst AD, Mach RH. PET imaging of microglial activation-beyond targeting TSPO. Molecules 2018; 23: https://doi.org/10.3390/molecules23030607.Suzuki Y, Nakamura Y, Yamada K, Kurabe S, Okamoto K, Aoki H, et al. Aquaporin positron emission tomography differentiates between grade III and IV human astrocytoma.
Janssen B,Vugts DJ,Windhorst AD,Mach RH。靶向TSPO以外的小胶质细胞激活的PET成像。分子2018;23条:https://doi.org/10.3390/molecules23030607.SuzukiY,Nakamura Y,Yamada K,Kurabe S,Okamoto K,Aoki H等。水通道蛋白正电子发射断层扫描区分III级和IV级人类星形细胞瘤。
Neurosurgery. 2018;82:842–6.Article .
神经外科。2018年;82:842-6。文章。
PubMed
PubMed
Google Scholar
谷歌学者
Chen Z, Yang A, Zhang J, Chen A, Zhang Y, Huang C, et al. CXCR4-Directed PET/CT with [(68)Ga]pentixafor in central nervous system lymphoma: a comparison with [(18)F]FDG PET/CT. Mol Imaging Biol. 2022;24:416–24.Article
Chen Z,Yang A,Zhang J,Chen A,Zhang Y,Huang C,et al。CXCR4导向PET/CT联合[(68)Ga]pentixafor治疗中枢神经系统淋巴瘤:与[(18)F]FDG PET/CT的比较。Mol Imaging Biol。2022年;24:416–24.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Starzer AM, Berghoff AS, Traub-Weidinger T, Haug AR, Widhalm G, Hacker M, et al. Assessment of central nervous system lymphoma based on CXCR4 expression in vivo using 68Ga-pentixafor PET/MRI. Clin Nucl Med. 2021;46:16–20.Article
Starzer AM,Berghoff AS,Traub Weidinger T,Haug AR,Widhalm G,Hacker M等。使用68Ga pentixafor PET/MRI在体内基于CXCR4表达评估中枢神经系统淋巴瘤。Clin Nucl Med。2021;46:16-20.文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
van der Wildt B, Wilhelmus MM, Bijkerk J, Haveman LY, Kooijman EJ, Schuit RC, et al. Development of carbon-11 labeled acryl amides for selective PET imaging of active tissue transglutaminase. Nucl Med Biol. 2016;43:232–42.Article
van der Wildt B,Wilhelmus MM,Bijkerk J,Haveman LY,Kooijman EJ,Schuit RC等。用于活性组织转谷氨酰胺酶选择性PET成像的碳-11标记丙烯酰胺的开发。Nucl医学生物学。2016年;43:232–42.文章
PubMed
PubMed
Google Scholar
谷歌学者
Ackermann U, Jager L, Rigopoulos A, Burvenich IJG, O’Keefe GJ, Scott AM. (18)F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2. Nucl Med Biol. 2023;116-117:108308.Meyer PT, Elmenhorst D, Matusch A, Winz O, Zilles K, Bauer A. A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humans.
Ackermann U,Jager L,Rigopoulos A,Burvinech IJG,O'Keefe GJ,Scott AM。(18)用于成像组织转谷氨酰胺酶2的Hitomi肽的F标记和初始体内评估。Nucl医学生物学。2023年;。
Neuroimage. 2006;32:1100–5.Article .
神经影像。2006年;32:1100–5。文章。
PubMed
PubMed
Google Scholar
谷歌学者
Barret O, Hannestad J, Vala C, Alagille D, Tavares A, Laruelle M, et al. Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors. J Nucl Med. 2015;56:586–91.Article
Barret O,Hannestad J,Vala C,Alagille D,Tavares A,Laruelle M等。18F-MNI-444(一种脑腺苷2A受体的PET放射性示踪剂)在人体中的表征。J Nucl Med。2015;
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Joya A, Ardaya M, Montilla A, Garbizu M, Plaza-Garcia S, Gomez-Vallejo V, et al. In vivo multimodal imaging of adenosine A(1) receptors in neuroinflammation after experimental stroke. Theranostics. 2021;11:410–25.Article
Joya A,Ardaya M,Montilla A,Garbizu M,Plaza Garcia S,Gomez-Vallejo V等。实验性中风后神经炎症中腺苷A(1)受体的体内多模式成像。治疗学。2021年;11: 410-25.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Rissanen E, Virta JR, Paavilainen T, Tuisku J, Helin S, Luoto P, et al. Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study. J Cereb Blood Flow Metab. 2013;33:1394–401.Article
Rissanen E,Virta JR,Paavilainen T,Tuisku J,Helin S,Luoto P等。继发性进行性多发性硬化症中的腺苷A2A受体:一项[(11)C]TMSX脑PET研究。。2013年;
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Karasawa A, Kawate T. Structural basis for subtype-specific inhibition of the P2X7 receptor. Elife 2016;5:e22153.McCarthy AE, Yoshioka C, Mansoor SE. Full-length P2X(7) structures reveal how palmitoylation prevents channel desensitization. Cell. 2019;179:659–670 e613.Article
Karasawa A,Kawate T.P2X7受体亚型特异性抑制的结构基础。Elife 2016;5: e22153.McCarthy AE,Yoshioka C,Mansoor SE。全长P2X(7)结构揭示了棕榈酰化如何防止通道脱敏。细胞。;179:659–670 e613。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Burnstock G, Boeynaems JM. Purinergic signalling and immune cells. Purinergic Signal. 2014;10:529–64.Article
Burnstock G,Boeynaems JM。嘌呤能信号传导和免疫细胞。嘌呤能信号。2014年;10: 529-64.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S. The P2X7 receptor in infection and inflammation. Immunity. 2017;47:15–31.Article
Di Virgilio F,Dal Ben D,Sarti AC,Giuliani AL,Falzoni S.感染和炎症中的P2X7受体。豁免。2017年;47:15–31.文章
PubMed
PubMed
Google Scholar
谷歌学者
Beltran-Lobo P, Reid MJ, Jimenez-Sanchez M, Verkhratsky A, Perez-Nievas BG, Noble W. Astrocyte adaptation in Alzheimer’s disease: a focus on astrocytic P2X7R. Essays Biochem. 2023;67:119–30.Article
Beltran Lobo P,Reid MJ,Jimenez-Sanchez M,Verkhratsky A,Perez-Nievas BG,Noble W.阿尔茨海默病中的星形胶质细胞适应:关注星形胶质细胞P2X7R。散文生物化学。2023年;67:119–30.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Illes P, Verkhratsky A, Burnstock G, Franke H. P2X receptors and their roles in astroglia in the central and peripheral nervous system. Neuroscientist. 2012;18:422–38.Article
Illes P,Verkhratsky A,Burnstock G,Franke H.P2X受体及其在中枢和周围神经系统星形胶质细胞中的作用。神经科学家。2012年;18: 422-38.文章
PubMed
PubMed
Google Scholar
谷歌学者
Bhattacharya A, Biber K. The microglial ATP-gated ion channel P2X7 as a CNS drug target. Glia. 2016;64:1772–87.Article
Bhattacharya A,Biber K.小胶质细胞ATP门控离子通道P2X7作为中枢神经系统药物靶标。。2016年;64:1772–87.文章
PubMed
PubMed
Google Scholar
谷歌学者
Illes P, Khan TM, Rubini P. Neuronal P2X7 receptors revisited: do they really exist? J Neurosci. 2017;37:7049–62.Article
Illes P,Khan TM,Rubini P.重新审视神经元P2X7受体:它们真的存在吗?J神经科学。2017年;37:7049–62.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Adinolfi E, Capece M, Amoroso F, De Marchi E, Franceschini A. Emerging roles of P2X receptors in cancer. Curr Med Chem. 2015;22:878–90.Article
Adinolfi E,Capece M,Amoroso F,De Marchi E,Franceschini A.P2X受体在癌症中的新兴作用。Curr Med化学。2015年;22:878–90.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov. 2008;7:575–90.Article
Burnstock G.嘌呤能信号传导和中枢神经系统疾病。Nat Rev Drug Discov公司。2008年;7: 575-90.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Monif M, Burnstock G, Williams DA. Microglia: proliferation and activation driven by the P2X7 receptor. Int J Biochem Cell Biol. 2010;42:1753–6.Article
Monif M,Burnstock G,Williams DA。小胶质细胞:由P2X7受体驱动的增殖和活化。Int J生物化学细胞生物学。2010年;42:1753–6.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Oliveira-Giacomelli A, Petiz LL, Andrejew R, Turrini N, Silva JB, Sack U, et al. Role of P2X7 receptors in immune responses during neurodegeneration. Front Cell Neurosci. 2021;15:662935.Article
Oliveira Giacomelli A,Petiz LL,Andrejew R,Turrini N,Silva JB,Sack U等。P2X7受体在神经退行性疾病免疫反应中的作用。前细胞神经科学。2021年;15: 662935条
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Territo PR, Zarrinmayeh H. P2X(7) receptors in neurodegeneration: potential therapeutic applications from basic to clinical approaches. Front Cell Neurosci. 2021;15:617036.Article
Territo PR,Zarrinmayeh H.P2X(7)受体在神经退行性疾病中的作用:从基础到临床的潜在治疗应用。前细胞神经科学。2021年;15: 第617036条
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
von Mucke-Heim IA, Deussing JM. The P2X7 receptor in mood disorders: emerging target in immunopsychiatry, from bench to bedside. Neuropharmacology. 2023;224:109366.Article
von Mucke Heim IA,Deussing JM。情绪障碍中的P2X7受体:免疫精神病学的新兴目标,从长凳到床边。神经药理学。2023年;224:109366.文章
Google Scholar
谷歌学者
Janssen B, Vugts DJ, Funke U, Spaans A, Schuit RC, Kooijman E, et al. Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [(1)(1)C]A-740003 as a novel tracer of neuroinflammation. J Labelled Comp Radiopharm. 2014;57:509–16.Article
Janssen B,Vugts DJ,Funke U,Spaans A,Schuit RC,Kooijman E等。P2X7受体拮抗剂[(1)(1)C]A-740003作为新型神经炎症示踪剂的合成和初步临床前评估。J标记的Comp Radiopharm。2014年;57:509–16.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Gao M, Wang M, Green MA, Hutchins GD, Zheng QH. Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor. Bioorg Med Chem Lett. 2015;25:1965–70.Article
高M,王M,马格林,哈钦斯GD,郑QH。[(11)C]GSK1482160作为靶向P2X(7)受体的新PET试剂的合成。Bioorg Med Chem Lett。2015年;25:1965–70.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Schmidt S, Isaak A, Junker A. Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star? Int J Mol Sci. 2023;24:1374.Territo PR, Meyer JA, Peters JS, Riley AA, McCarthy BP, Gao M, et al. Characterization of (11)C-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation.
Schmidt S,Isaak A,Junker A.聚焦P2X7受体PET成像:明亮的目标还是失败的恒星?国际分子科学杂志。2023年;24:1374.Territo PR,Meyer JA,Peters JS,Riley AA,McCarthy BP,Gao M等人(11)C-GSK1482160的表征,用于靶向P2X7受体作为神经炎症的生物标志物。
J Nucl Med. 2017;58:458–65.Article .
《核医学杂志》2017年;58:458-65.文章[联合王国]。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Huang G, Lu X, Qiu Y, Bi L, Ye P, Yang M, et al. Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [(18)F]GSK1482160. Bioorg Med Chem. 2022;73:116996.Article
Huang G,Lu X,Qiu Y,Bi L,Ye P,Yang M,等。新型正电子发射断层扫描(PET)示踪剂[(18)F]GSK1482160的杂芳基溴前体氟-18放射合成和临床前评估。Bioorg医学化学。2022年;73:116996.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Hagens MHJ, Golla SSV, Janssen B, Vugts DJ, Beaino W, Windhorst AD, et al. The P2X7 receptor tracer [(11)C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study. Eur J Nucl Med Mol Imaging. 2020;47:379–89.Article
Hagens MHJ,Golla SSV,Janssen B,Vugts DJ,Beaino W,Windhorst AD等。P2X7受体示踪剂[(11)C]SMW139作为多发性硬化症神经炎症的体内标志物:首次人体研究。Eur J Nucl Med Mol成像。2020年;47:379-89.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Ory D, Celen S, Gijsbers R, Van Den Haute C, Postnov A, Koole M, et al. Preclinical evaluation of a P2X7 receptor-selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in nonhuman primates. J Nucl Med. 2016;57:1436–41.Article
Ory D,Celen S,Gijsbers R,Van Den Haute C,Postnov A,Koole M等。P2X7受体选择性放射性示踪剂的临床前评估:在人类P2X7受体局部过表达的大鼠模型和非人灵长类动物中进行PET研究。J Nucl Med。2016;57:1436–41.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kolb HC, Barret O, Bhattacharya A, Chen G, Constantinescu C, Huang C, et al. Preclinical evaluation and nonhuman primate receptor occupancy study of (18)F-JNJ-64413739, a PET radioligand for P2X7 receptors. J Nucl Med. 2019;60:1154–9.Article
Kolb HC,Barret O,Bhattacharya A,Chen G,Constantinescu C,Huang C等。P2X7受体的PET放射性配体(18)F-JNJ-64413739的临床前评估和非人灵长类受体占有率研究。J Nucl Med。2019;60:1154–9.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Van Weehaeghe D, Koole M, Schmidt ME, Deman S, Jacobs AH, Souche E.et al. (11)C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers.
Van Weehaeghe D,Koole M,Schmidt ME,Deman S,Jacobs AH,Souche E.et al。(11)C]JNJ54173717,一种新型P2X7受体放射性配体,作为神经炎症的标志物:人类生物分布,剂量测定,脑动力学建模和帕金森病患者和健康志愿者脑P2X7受体的定量。
Eur J Nucl Med Mol Imaging. 2019;46:2051–64.Koole M, Schmidt ME, Hijzen A, Ravenstijn P, Vandermeulen C, Van Weehaeghe D.et al. (18)F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: radiation dosimetry, kinetic modeling, test-retest variability, and occupancy of the P2X7 antagonist JNJ-54175446.
Eur J Nucl Med Mol成像。;46:2051–64.Koole M,Schmidt ME,Hijzen A,Ravenstijn P,Vandermeulen C,Van Weehaeghe D.et al。(18)F-JNJ-64413739,P2X7离子通道的新型PET配体:辐射剂量测定,动力学建模,重测变异性和P2X7拮抗剂JNJ-54175446的占用率。
J Nucl Med. 2019;60:683–90.Mertens N, Schmidt ME, Hijzen A, Van Weehaeghe D, Ravenstijn P, Depre M, et al. Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [(18)F]JNJ-64413739 PET and MRA-driven image derived input function. Sci Rep. 2021;11:16172.Article .
J Nucl Med。2019;60:683–90.Mertens N,Schmidt ME,Hijzen A,Van Weehaeghe D,Ravenstijn P,Depre M等。使用动态[(18)F]JNJ-64413739 PET和MRA驱动的图像衍生输入函数对大脑P2X7R占用进行微创定量。Sci代表2021;11: 。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Mikkelsen JD, Aripaka SS, Kaad S, Pazarlar BA, Pinborg L, Finsen B, et al. Characterization of the novel P2X7 receptor radioligand [(3)H]JNJ-64413739 in human brain tissue. ACS Chem Neurosci. 2023;14:111–8.Article
Mikkelsen JD,Aripaka SS,Kaad S,Pazarlar BA,Pinborg L,Finsen B等。人脑组织中新型P2X7受体放射性配体[(3)H]JNJ-64413739的表征。ACS化学神经科学。2023年;14: 111-8.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Notter T, Coughlin JM, Sawa A, Meyer U. Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry. Mol Psychiatry. 2018;23:36–47.Article
Notter T,Coughlin JM,Sawa A,Meyer U.将易位蛋白重新概念化为精神病学中神经炎症的生物标志物。摩尔精神病学。2018年;23:36–47.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Van Weehaeghe D, Van Schoor E, De Vocht J, Koole M, Attili B, Celen S, et al. TSPO versus P2X7 as a target for neuroinflammation: an in vitro and in vivo study. J Nucl Med. 2020;61:604–7.Article
。J Nucl Med。2020;61:604–7.文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131–43.Article
Butovsky O,Jedrychowski MP,Moore CS,Cialic R,Lanser AJ,Gabriely G等。鉴定小胶质细胞中独特的TGF-β依赖性分子和功能特征。Nat Neurosci。2014年;17: 131-43.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell. 2017;169:1276–1290 e1217.Article
Keren Shaul H,Spinrad A,Weiner A,Matcovitch Natan O,Dvir Szternfeld R,Ulland TK等。一种独特的小胶质细胞类型,与限制阿尔茨海默病的发展有关。细胞。2017年;169:1276–1290 e1217。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, et al. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci USA. 2016;113:E1738–1746.Article
Bennett ML,Bennett FC,Liddelow SA,Ajami B,Zamanian JL,Fernhoff NB等。研究小鼠和人类中枢神经系统小胶质细胞的新工具。美国国家科学院院刊2016;113:E1738-1746.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Zhu C, Kros JM, van der Weiden M, Zheng P, Cheng C, Mustafa DA. Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade. Acta Neuropathol Commun. 2017;5:4.Article
Zhu C,Kros JM,van der Weiden M,Zheng P,Cheng C,Mustafa DA。星形细胞瘤中居住小胶质细胞中P2RY12的表达位点与M1和M2标记物表达和肿瘤分级相关。神经病理学学报。2017年;5: 4、条款
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19:622–35.Article
Butovsky O,Weiner HL。小胶质细胞特征及其在健康和疾病中的作用。Nat Rev Neurosci。2018年;19: 622-35.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner HL, Lassmann H. Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis. Brain. 2017;140:1900–13.Article
Zrzavy T,Hametner S,Wimmer I,Butovsky O,Weiner HL,Lassmann H.“稳态”小胶质细胞的丧失及其在活动性多发性硬化症中的激活模式。大脑。2017年;140:1900–13.文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566–581 e569.Article
Krasemann S,Madore C,Cialic R,Baufeld C,Calcagno N,El Fatimy R等。TREM2-APOE途径驱动神经退行性疾病中功能失调的小胶质细胞的转录表型。豁免。2017年;47:566–581 e569。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Beaino W, Janssen B, Kooij G, van der Pol SMA, van Het Hof B, van Horssen J, et al. Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis. J Neuroinflammation. 2017;14:259.Article
Beaino W,Janssen B,Kooij G,van der Pol SMA,van Het Hof B,van Horssen J等。嘌呤能受体P2Y12R和P2X7R:多发性硬化症小胶质细胞表型PET成像的潜在靶点。J神经炎症。2017年;14: 第259条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Klein B, Mrowetz H, Barker CM, Lange S, Rivera FJ, Aigner L. Age influences microglial activation after cuprizone-induced demyelination. Front Aging Neurosci. 2018;10:278.Article
Klein B,Mrowetz H,Barker CM,Lange S,Rivera FJ,Aigner L.年龄影响铜氮酮诱导的脱髓鞘后的小胶质细胞活化。前衰老神经科学。2018年;10: 第278条
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Maeda J, Minamihisamatsu T, Shimojo M, Zhou X, Ono M, Matsuba Y, et al. Distinct microglial response against Alzheimer’s amyloid and tau pathologies characterized by P2Y12 receptor. Brain Commun. 2021;3:fcab011.Article
Maeda J,Minamihisamatsu T,Shimojo M,Zhou X,Ono M,Matsuba Y等。针对以P2Y12受体为特征的阿尔茨海默氏症淀粉样蛋白和tau病理的不同小胶质细胞反应。大脑通讯。2021年;3: fcab011。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Baqi Y, Muller CE. Antithrombotic P2Y(12) receptor antagonists: recent developments in drug discovery. Drug Discov Today. 2019;24:325–33.Article
巴奇Y,穆勒CE。抗血栓P2Y(12)受体拮抗剂:药物发现的最新进展。今天发现了毒品。;24:325–33.文章
PubMed
PubMed
Google Scholar
谷歌学者
Janssen AL, Vugts DJ, Funke U, Molenaar GT, Kruijer PS, Dolle F et al. Synthesis of the first carbon-11 labelled P2Y12 receptor antagonist for PET imaging of microglial activation in neuroinflammation. Proc J Labelled Comp Radiopharmaceuticals. 2015;58:S44.Villa A, Klein B, Janssen B, Pedragosa J, Pepe G, Zinnhardt B, et al.
Janssen等,Vugts DJ,Funke U,Molenaar GT,Kruijer PS,Dolle F等。第一种碳-11标记的P2Y12受体拮抗剂的合成,用于PET成像神经炎症中小胶质细胞的激活。Proc J标记的Comp放射性药物。2015年;58:S44.Villa A,Klein B,Janssen B,Pedragosa J,Pepe G,Zinnhardt B等。
Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state. Theranostics. 2018;8:5400–18.Article .
鉴定小胶质细胞抗炎激活状态PET成像的新分子靶标。治疗学。2018年;8: 5400-18条。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Jackson IM, Buccino PJ, Azevedo EC, Carlson ML, Luo ASZ, Deal EM, et al. Radiosynthesis and initial preclinical evaluation of [(11)C]AZD1283 as a potential P2Y12R PET radiotracer. Nucl Med Biol. 2022;114-115:143–50.Article
Jackson IM,Buccino PJ,Azevedo EC,Carlson ML,Luo ASZ,Deal EM等人,[(11)C]AZD1283作为潜在P2Y12R PET放射性示踪剂的放射合成和初步临床前评估。Nucl医学生物学。2022年;114-115:143-50.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
van der Wildt B, Janssen B, Pekosak A, Steen EJL, Schuit RC, Kooijman EJM, et al. Novel thienopyrimidine-based PET Tracers for P2Y(12) receptor imaging in the brain. ACS Chem Neurosci. 2021;12:4465–74.Article
van der Wildt B,Janssen B,Pekosak A,Steen EJL,Schuit RC,Kooijman EJM等。用于大脑P2Y(12)受体成像的新型噻吩并嘧啶PET示踪剂。ACS化学神经科学。2021年;12: 4465–74.文章
PubMed
PubMed
Google Scholar
谷歌学者
Xiang C, Li H, Tang W. Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases. Pharmacol Res. 2023;187:106566.Article
Xiang C,Li H,Tang W.靶向CSF-1R代表了调节炎症性疾病的有效策略。Pharmacol Res.2023;187:106566.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Chitu V, Biundo F, Stanley ER. Colony stimulating factors in the nervous system. Semin Immunol. 2021;54:101511.Article
Chitu V,Biundo F,Stanley ER。神经系统中的集落刺激因子。Semin免疫。2021年;54:101511.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Bernard-Gauthier V, Schirrmacher R. 5-(4-((4-[(18)F]Fluorobenzyl)oxy)-3-methoxybenzyl)pyrimidine-2,4-diamine: a selective dual inhibitor for potential PET imaging of Trk/CSF-1R. Bioorg Med Chem Lett. 2014;24:4784–90.Article
Bernard Gauthier V,Schirrmacher R.5-(4-((4-[(18)F]氟苄基)氧基)-3-甲氧基苄基)嘧啶-2,4-二胺:用于Trk/CSF-1R潜在PET成像的选择性双重抑制剂。Bioorg Med Chem Lett。2014年;
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Singleton TA, Bdair H, Bailey JJ, Choi S, Aliaga A, Rosa-Neto P, et al. Efficient radiosynthesis and preclinical evaluation of [(18) F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging. J Labelled Comp Radiopharm. 2020;63:144–50.Article
Singleton TA,Bdair H,Bailey JJ,Choi S,Aliaga A,Rosa Neto P等人,[(18)F]FOMPyD作为TrkB/C受体成像的正电子发射断层扫描示踪剂候选物的有效放射合成和临床前评估。J标记的Comp Radiopharm。2020年;63:144–50.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
van der Wildt B, Miao Z, Reyes ST, Park JH, Klockow JL, Zhao N, et al. BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain. Nucl Med Biol. 2021;100-101:44–51.Article
van der Wildt B,Miao Z,Reyes ST,Park JH,Klockow JL,Zhao N,et al。BLZ945衍生物用于大脑中集落刺激因子-1受体的PET成像。Nucl医学生物学。2021年;100-101:44-51.文章
PubMed
PubMed
Google Scholar
谷歌学者
Tanzey SS, Shao X, Stauff J, Arteaga J, Sherman P, Scott PJH, et al. Synthesis and initial in vivo evaluation of [(11)C]AZ683-A novel PET radiotracer for colony stimulating factor 1 receptor (CSF1R). Pharmaceuticals (Basel). 2018;11:136.Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, et al.
Tanzey SS,Shao X,Stauff J,Arteaga J,Sherman P,Scott PJH等。集落刺激因子1受体(CSF1R)的新型PET放射性示踪剂[(11)C]AZ683的合成和初步体内评价。制药(巴塞尔)。2018年;11: 霍蒂AG,奈克R,福斯CA,明尼苏达州I,米舍内瓦V,杜Y等。
PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). Proc Natl Acad Sci USA. 2019;116:1686–91.Article .
通过靶向巨噬细胞集落刺激因子1受体(CSF1R)对小胶质细胞进行PET成像。美国国家科学院院刊2019;116:1686-91。文章。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Mathews WB, Wu Y, Horti AG, Naik R, Hall AW, Holt DP, et al. Radiosynthesis and validation of [5-cyano-N-(4-(4-[(11) C]methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl) furan-2-carboxamide] ([(11) C]CPPC), a PET radiotracer for imaging CSF1R, a microglia-specific marker. J Labelled Comp Radiopharm.
Mathews WB,Wu Y,Horti AG,Naik R,Hall AW,Holt DP等[5-氰基-N-(4-(4-[(11)C]甲基哌嗪-1-基)-2-(哌啶-1-基)苯基)呋喃-2-甲酰胺]([(11)C]CPPC)的放射合成和验证,一种PET放射性示踪剂,用于成像CSF1R,一种小胶质细胞特异性标记。J标记的Comp Radiopharm。
2019;62:903–8.Coughlin JM, Du Y, Lesniak WG, Harrington CK, Brosnan MK, O’Toole R, et al. First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor. EJNMMI Res. 2022;12:64.Article .
;62:903–8.Coughlin JM,Du Y,Lesniak WG,Harrington CK,Brosnan MK,O'Toole R等。首次在人类中使用(11)C-CPPC和正电子发射断层扫描对巨噬细胞集落刺激因子1受体进行成像。EJNMMI Res.2022;12: 第64条。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Knight AC, Varlow C, Zi T, Liang SH, Josephson L, Schmidt K, et al. In vitro evaluation of [(3)H]CPPC as a tool radioligand for CSF-1R. ACS Chem Neurosci. 2021;12:998–1006.Article
Knight AC,Varlow C,Zi T,Liang SH,Josephson L,Schmidt K等。体外评估[(3)H]CPPC作为CSF-1R的工具放射性配体。ACS化学神经科学。2021年;12: 998–1006.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Rubin LH, Du Y, Sweeney SE, O’Toole R, Harrington CK, Jenkins K, et al. Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV. AIDS. 2023;37:1419–24.Article
Rubin LH,Du Y,Sweeney SE,O'Toole R,Harrington CK,Jenkins K等。HIV病毒感染者大脑中集落刺激因子1受体的初步成像。艾滋病。2023年;37:1419–24.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Venneti S, Wang G, Wiley CA. Activated macrophages in HIV encephalitis and a macaque model show increased [3H](R)-PK11195 binding in a PI3-kinase-dependent manner. Neurosci Lett. 2007;426:117–22.Article
Venneti S,Wang G,Wiley CA。HIV脑炎和猕猴模型中活化的巨噬细胞以PI3激酶依赖性方式显示[3H](R)-PK11195结合增加。神经科学Lett。2007年;426:117-22.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Garvey LJ, Pavese N, Ramlackhansingh A, Thomson E, Allsop JM, Politis M, et al. Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation. PLoS ONE. 2012;7:e38980.Article
Garvey LJ,Pavese N,Ramlakhansingh A,Thomson E,Allsop JM,Politis M等。急性HCV/HIV合并感染与认知功能障碍和脑代谢物紊乱有关,但与小胶质细胞活化无关。PLoS ONE。2012年;7: e38980。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Coughlin JM, Wang Y, Ma S, Yue C, Kim PK, Adams AV, et al. Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV. J Neurovirol. 2014;20:219–32.Article
Coughlin JM,Wang Y,Ma S,Yue C,Kim PK,Adams AV等。使用[(11)C]DPA-713 PET在HIV感染者中转运蛋白的区域脑分布。J Neurovirol。2014年;20: 219-32.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Garvey LJ, Pavese N, Politis M, Ramlackhansingh A, Brooks DJ, Taylor-Robinson SD, et al. Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS. 2014;28:67–72.Article
Garvey LJ,Pavese N,Politis M,Ramlakhansingh A,Brooks DJ,Taylor Robinson SD等。接受有效抗逆转录病毒治疗的无神经症状HIV感染患者的小胶质细胞活化增加。2014年;28:67–72.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Vera JH, Guo Q, Cole JH, Boasso A, Greathead L, Kelleher P, et al. Neuroinflammation in treated HIV-positive individuals: a TSPO PET study. Neurology. 2016;86:1425–32.Article
Vera JH,Guo Q,Cole JH,Boasso A,Greathead L,Kelleher P等。治疗后HIV阳性个体的神经炎症:TSPO PET研究。神经病学。2016年;86:1425–32.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Rubin LH, Sacktor N, Creighton J, Du Y, Endres CJ, Pomper MG, et al. Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy. AIDS. 2018;32:1661–7.Article
Rubin LH,Sacktor N,Creighton J,Du Y,Endres CJ,Pomper MG等。小胶质细胞激活与HIV感染者对有效抗逆转录病毒治疗的认知呈负相关。艾滋病。2018年;32:1661–7.文章
PubMed
PubMed
Google Scholar
谷歌学者
Boerwinkle AH, Strain JF, Burdo T, Doyle J, Christensen J, Su Y, et al. Comparison of [11C]-PBR28 binding between persons living with HIV and HIV-uninfected individuals. J Acquir Immune Defic Syndr. 2020;85:244–51.Article
Boerwinkle AH,Strain JF,Burdo T,Doyle J,Christensen J,Su Y等。HIV感染者和HIV未感染者之间[11C]-PBR28结合的比较。J Acquir Immune Defic Syndr。2020年;85:244–51.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Zhou X, Ji B, Seki C, Nagai Y, Minamimoto T, Fujinaga M, et al. PET imaging of colony-stimulating factor 1 receptor: A head-to-head comparison of a novel radioligand, (11)C-GW2580, and (11)C-CPPC, in mouse models of acute and chronic neuroinflammation and a rhesus monkey. J Cereb Blood Flow Metab.
Zhou X,Ji B,Seki C,Nagai Y,Minamimoto T,Fujinaga M等。集落刺激因子1受体的PET成像:新型放射性配体,(11)C-GW2580和(11)C-CPPC在急性和慢性神经炎症小鼠模型和恒河猴中的头对头比较。J Cereb血流代谢。
2021;41:2410–22.Article .
2021年;41:2410-22。文章。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Altomonte S, Yan X, Morse CL, Liow JS, Jenkins MD, Montero Santamaria JA, et al. Discovery of a high-affinity fluoromethyl analog of [(11)C]5-Cyano-N-(4-(4-methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide ([(11)C]CPPC) and their comparison in mouse and monkey as colony-stimulating factor 1 receptor positron emission tomography radioligands.
Altomonte S,Yan X,Morse CL,Liow JS,Jenkins MD,Montero Santamaria JA,et al。发现[(11)C]5-氰基-N-(4-(4-甲基哌嗪-1-基)-2-(哌啶-1-基)苯基)呋喃-2-甲酰胺([(11)C]CPPC)的高亲和力氟甲基类似物及其在小鼠和猴中作为集落刺激因子1受体正电子发射断层扫描放射性配体的比较。
ACS Pharmacol Transl Sci. 2023;6:614–32.Article .
ACS Pharmacol Transl Sci。2023年;6: 614-32条。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
van der Wildt B, Nezam M, Kooijman EJM, Reyes ST, Shen B, Windhorst AD, et al. Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain. Bioorg Med Chem. 2021;42:116245.Article .
van der Wildt B,Nezam M,Kooijman EJM,Reyes ST,Shen B,Windhorst AD等。碳-11标记的5-(1-甲基-1H-吡唑-4-基)-N-(2-甲基-5-(3-(三氟甲基)苯甲酰胺基)苯基)烟酰胺作为PET示踪剂用于脑中CSF-1R表达成像的评估。Bioorg医学化学。2021年;42:116245。第条。
PubMed
PubMed
Google Scholar
谷歌学者
van der Wildt B, Klockow JL, Miao Z, Reyes ST, Park JH, Shen B, et al. Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain. Nucl Med Biol. 2022;114-115:99–107.Article
van der Wildt B,Klockow JL,Miao Z,Reyes ST,Park JH,Shen B等。发现CSF-1R抑制剂和PET示踪剂用于大脑中小胶质细胞和巨噬细胞的成像。Nucl医学生物学。2022年;114-115:99-107.文章
PubMed
PubMed
Google Scholar
谷歌学者
Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19:1264–72.Article
Pyonteck SM,Akkari L,Schuhmacher AJ,Bowman RL,Sevenich L,Quail DF等。CSF-1R抑制改变巨噬细胞极化并阻断胶质瘤进展。Nat Med。2013;19: 1264-72.条
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Ramachandran SA, Jadhavar PS, Miglani SK, Singh MP, Kalane DP, Agarwal AK, et al. Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors. Bioorg Med Chem Lett. 2017;27:2153–60.Article
Ramachandran SA,Jadhavar PS,Miglani SK,Singh MP,Kalane DP,Agarwal AK等。双酰胺衍生物作为CSF1R抑制剂的设计,合成和优化。Bioorg Med Chem Lett。2017年;27:2153–60.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Lee H, Park JH, Kim H, Woo SK, Choi JY, Lee KH, et al. Synthesis and evaluation of a (18)F-labeled ligand for PET imaging of colony-stimulating factor 1 receptor. Pharmaceuticals (Basel). 2022;15:276.An X, Wang J, Tong L, Zhang X, Fu H, Zhang J.et al. (18)F-Labeled o‑aminopyridyl alkynyl radioligands targeting colony-stimulating factor 1 receptor for neuroinflammation imaging.
Lee H,Park JH,Kim H,Woo SK,Choi JY,Lee KH等。用于集落刺激因子1受体PET成像的(18)F标记配体的合成和评估。制药(巴塞尔)。2022年;15: An X,Wang J,Tong L,Zhang X,Fu H,Zhang J.等(18)F标记的o-氨基吡啶基炔基放射性配体靶向集落刺激因子1受体用于神经炎症成像。
Bioorg Med Chem. 2023;83:117233.Xie Z, Wu B, Liu Y, Ren W, Tong L, Xiang C, et al. Novel class of colony-stimulating factor 1 receptor kinase inhibitors based on an o-aminopyridyl alkynyl scaffold as potential treatment for inflammatory disorders. J Med Chem. 2020;63:1397–414.Article .
Bioorg医学化学。2023年;83:117233.Xie Z,Wu B,Liu Y,Ren W,Tong L,Xiang C等。基于邻氨基吡啶基炔基支架的新型集落刺激因子1受体激酶抑制剂作为炎症性疾病的潜在治疗方法。J医学化学。2020年;63:1397-414。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Ghazanfari N, van Waarde A, Dierckx R, Doorduin J, de Vries EFJ. Is cyclooxygenase-1 involved in neuroinflammation? J Neurosci Res. 2021;99:2976–98.Article
Ghazanfari N,van Waarde A,Dierckx R,Doorduin J,de Vries EFJ。环氧合酶-1是否参与神经炎症?;99:2976–98.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
McCarthy TJ, Sheriff AU, Graneto MJ, Talley JJ, Welch MJ. Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitors. J Nucl Med. 2002;43:117–24.CAS
麦卡锡TJ,AU警长,Graneto MJ,Talley JJ,Welch MJ。18F标记的COX-1和COX-2抑制剂的放射合成,体外验证和体内评估。J Nucl Med。2002;43:117–24.CAS
PubMed
PubMed
Google Scholar
谷歌学者
Prabhakaran J, Underwood MD, Parsey RV, Arango V, Majo VJ, Simpson NR, et al. Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide as a PET imaging probe for COX-2 expression. Bioorg Med Chem. 2007;15:1802–7.Ji B, Kumata K, Onoe H, Kaneko H, Zhang MR, Seki C, et al.
Prabhakaran J,Underwood MD,Parsey RV,Arango V,Majo VJ,Simpson NR等[18F]-4-[5-(4-甲基苯基)-3-(三氟甲基)-1H-吡唑-1-基]苯磺酰胺作为COX-2表达的PET成像探针的合成和体内评价。Bioorg医学化学。2007年;15: 1802-7.Ji B,Kumata K,Onoe H,Kaneko H,Zhang MR,Seki C等。
Assessment of radioligands for PET imaging of cyclooxygenase-2 in an ischemic neuronal injury model. Brain Res. 2013;1533:152–62.Article .
缺血性神经元损伤模型中环加氧酶-2 PET成像的放射性配体的评估。Brain Res.2013;1533:152-62。第条。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kumar JSD, Bai B, Zanderigo F, DeLorenzo C, Prabhakaran J, Parsey RV, et al. In vivo brain imaging, biodistribution, and radiation dosimetry estimation of [(11)C]Celecoxib, a COX-2 PET ligand, in nonhuman primates. Molecules. 2018;23:1929.de Vries EF, Doorduin J, Dierckx RA, van Waarde A.
Kumar JSD,Bai B,Zanderigo F,DeLorenzo C,Prabhakaran J,Parsey RV等。COX-2 PET配体[(11)C]塞来昔布在非人灵长类动物中的体内脑成像,生物分布和辐射剂量学估计。分子。2018年;23:1929.de Vries EF,Doorduin J,Dierckx RA,van Waarde A。
Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation. Nucl Med Biol. 2008;35:35–42.Article .
。Nucl医学生物学。2008年;35:35-42。第条。
PubMed
PubMed
Google Scholar
谷歌学者
Toyokuni T, Kumar JS, Walsh JC, Shapiro A, Talley JJ, Phelps ME, et al. Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography.
。
Bioorg Med Chem Lett. 2005;15:4699–702.Article .
Bioorg With Chem Easy。2005;15:4699-702文章集。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Prabhakaran J, Underwood M, Zanderigo F, Simpson NR, Cooper AR, Matthew J, et al. Radiosynthesis and in vivo evaluation of [(11)C]MOV as a PET imaging agent for COX-2. Bioorg Med Chem Lett. 2018;28:2432–5.Article
Prabhakaran J,Underwood M,Zanderigo F,Simpson NR,Cooper AR,Matthew J等人,[(11)C]MOV作为COX-2 PET显像剂的放射合成和体内评估。Bioorg Med Chem Lett。2018年;28:2432–5.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Yamamoto Y, Toyohara J, Ishiwata K, Sano K, Yamamoto F, Mukai T, et al. (1)C-labeled analogs of indomethacin esters and amides for brain cyclooxygenase-2 imaging: radiosynthesis, in vitro evaluation and in vivo characteristics in mice. Chem Pharm Bull (Tokyo). 2011;59:938–46.Yamamoto Y, Tago T, Toyohara J, Saito Y, Yamamoto F.
Yamamoto Y,Toyohara J,Ishiwata K,Sano K,Yamamoto F,Mukai T等。(1)用于脑环氧合酶-2成像的吲哚美辛酯和酰胺的C标记类似物:放射合成,体外评估和小鼠体内特征。Chem Pharm Bull(东京)。2011年;59:938-46.Yamamoto Y,Tago T,Toyohara J,Saito Y,Yamamoto F。
Radiosynthesis and in vivo and ex vivo evaluation of isomeric [(11)C]methoxy analogs of nimesulide as brain cyclooxygenase-2-targeted imaging agents. Biol Pharm Bull. 2022;45:94–103.Article .
尼美舒利的异构[(11)C]甲氧基类似物作为脑环氧合酶-2靶向显像剂的放射合成和体内外评价。生物制药公牛。2022年;45:94-103。第条。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Elie J, Vercouillie J, Arlicot N, Lemaire L, Bidault R, Bodard S, et al. Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer. J Enzyme Inhib Med Chem. 2019;34:1–7.Article
Elie J,Vercouillie J,Arlicot N,Lemaire L,Bidault R,Bodard S等(aza)吲唑系列选择性COX-2抑制剂的设计。[(18)F]PET示踪剂的化学,体外研究,放射化学和大鼠评估。J酶抑制剂Med Chem。;34:1–7.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Cortes-Salva MY, Shrestha S, Singh P, Morse CL, Jenko KJ, Montero Santamaria JA et al. 2-(4-methylsulfonylphenyl)pyrimidines as prospective radioligands for imaging cyclooxygenase-2 with PET-synthesis, triage, and radiolabeling. Molecules. 2018;23:2850.Kim MJ, Shrestha SS, Cortes M, Singh P, Morse C, Liow JS, et al.
Cortes Salva MY,Shrestha S,Singh P,Morse CL,Jenko KJ,Montero Santamaria JA等人。2-(4-甲基磺酰基苯基)嘧啶作为前瞻性放射性配体,用于通过PET合成,分类和放射性标记对环氧合酶-2进行成像。分子。2018年;23:2850.Kim MJ,Shrestha SS,Cortes M,Singh P,Morse C,Liow JS等。
Evaluation of two potent and selective PET radioligands to image COX-1 and COX-2 in rhesus monkeys. J Nucl Med. 2018;59:1907–12.Article .
评估两种有效和选择性PET放射性配体在恒河猴中成像COX-1和COX-2。J Nucl Med。2018;59:1907-12。文章。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Shrestha S, Kim MJ, Eldridge M, Lehmann ML, Frankland M, Liow JS, et al. PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study. J Neuroinflammation. 2020;17:140.Article
Shrestha S,Kim MJ,Eldridge M,Lehmann ML,Frankland M,Liow JS等。使用新型放射性配体对环氧合酶-2进行PET测量:灵长类神经炎症中的上调,并首次在人类研究中进行。J神经炎症。2020年;17: 140、条款
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Kumar JSD, Zanderigo F, Prabhakaran J, Rubin-Falcone H, Parsey RV, Mann JJ. In vivo evaluation of [(11)C]TMI, a COX-2 selective PET tracer, in baboons. Bioorg Med Chem Lett. 2018;28:3592–5.Article
Kumar JSD,Zanderigo F,Prabhakaran J,Rubin Falcone H,Parsey RV,Mann JJ。在狒狒体内评估COX-2选择性PET示踪剂[(11)C]TMI。Bioorg Med Chem Lett。2018年;28:3592–5.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Prabhakaran J, Molotkov A, Mintz A, Mann JJ. Progress in PET imaging of neuroinflammation targeting COX-2 enzyme. Molecules. 2021;26:3208.Shukuri M, Takashima-Hirano M, Tokuda K, Takashima T, Matsumura K, Inoue O, et al. In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester.
Prabhakaran J,Molotkov A,Mintz A,Mann JJ。。分子。2021年;26:3208.Shukuri M,Takashima Hirano M,Tokuda K,Takashima T,Matsumura K,Inoue O等。用11C-酮洛芬甲酯PET观察活化的小胶质细胞和巨噬细胞在神经炎症过程中环氧合酶-1的体内表达。
J Nucl Med. 2011;52:1094–101.Article .
《核医学杂志》,2011年;52:1094–101.文章[联合王国]。
PubMed
PubMed
Google Scholar
谷歌学者
Shukuri M, Mawatari A, Ohno M, Suzuki M, Doi H, Watanabe Y, et al. Detection of cyclooxygenase-1 in activated microglia during amyloid plaque progression: PET studies in Alzheimer’s disease model mice. J Nucl Med. 2016;57:291–6.Article
Shukuri M,Mawatari A,Ohno M,Suzuki M,Doi H,Watanabe Y等。淀粉样斑块进展过程中活化小胶质细胞中环加氧酶-1的检测:阿尔茨海默病模型小鼠的PET研究。J Nucl Med。2016;57:291–6.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Shukuri M, Mawatari A, Takatani S, Tahara T, Inoue M, Arakaki W, et al. Synthesis and preclinical evaluation of (18)F-labeled ketoprofen methyl esters for cyclooxygenase-1 imaging in neuroinflammation. J Nucl Med. 2022;63:1761–7.CAS
Shukuri M,Mawatari A,Takatani S,Tahara T,Inoue M,Arakaki W等。用于神经炎症中环加氧酶-1成像的(18)F标记酮洛芬甲酯的合成和临床前评估。J Nucl Med。2022;63:1761-7.CAS
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Singh P, Shrestha S, Cortes-Salva MY, Jenko KJ, Zoghbi SS, Morse CL, et al. 3-Substituted 1,5-Diaryl-1 H-1,2,4-triazoles as prospective PEt radioligands for imaging brain COX-1 in Monkey. Part 1: synthesis and pharmacology. ACS Chem Neurosci. 2018;9:2610–9.Article
Singh P,Shrestha S,Cortes Salva MY,Jenko KJ,Zoghbi SS,Morse CL等。3-取代的1,5-二芳基-1H-1,2,4-三唑作为前瞻性PEt放射性配体,用于成像猴子的大脑COX-1。第1部分:合成和药理学。ACS化学神经科学。2018年;9: 2610–9.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Shrestha S, Singh P, Cortes-Salva MY, Jenko KJ, Ikawa M, Kim MJ, et al. 3-substituted 1,5-Diaryl-1 H-1,2,4-triazoles as prospective PET radioligands for imaging brain COX-1 in Monkey. Part 2: Selection and evaluation of [(11)C]PS13 for quantitative imaging. ACS Chem Neurosci. 2018;9:2620–7.Article .
Shrestha S,Singh P,Cortes Salva MY,Jenko KJ,Ikawa M,Kim MJ等。3-取代的1,5-二芳基-1H-1,2,4-三唑作为前瞻性PET放射性配体,用于成像猴子的大脑COX-1。第二部分:[(11)C]PS13定量成像的选择与评价。ACS化学神经科学。2018年;9: 2620-7。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kim MJ, Lee JH, Juarez Anaya F, Hong J, Miller W, Telu S, et al. First-in-human evaluation of [(11)C]PS13, a novel PET radioligand, to quantify cyclooxygenase-1 in the brain. Eur J Nucl Med Mol Imaging. 2020;47:3143–51.Article
Kim MJ,Lee JH,Juarez Anaya F,Hong J,Miller W,Telu S等。首次对新型PET放射性配体[(11)C]PS13进行人体评估,以定量大脑中的环氧合酶-1。Eur J Nucl Med Mol成像。2020年;47:3143–51.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Kim MJ, Anaya FJ, Manly LS, Lee JH, Hong J, Shrestha S, et al. Whole-body PET imaging in humans shows that (11)C-PS13 is selective for cyclooxygenase-1 and can measure the in vivo potency of nonsteroidal antiinflammatory drugs. J Nucl Med. 2023;64:159–64.Article
Kim MJ,Anaya FJ,Manly LS,Lee JH,Hong J,Shrestha S等。人体全身PET成像显示(11)C-PS13对环氧合酶-1具有选择性,可以测量非甾体类抗炎药的体内效力。J Nucl Med。2023;64:159–64.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Taddei C, Morse CL, Kim MJ, Liow JS, Montero Santamaria J, Zhang A, et al. Synthesis of [(18)F]PS13 and evaluation as a PET radioligand for cyclooxygenase-1 in Monkey. ACS Chem Neurosci. 2021;12:517–30.Article
Taddei C,Morse CL,Kim MJ,Liow JS,Montero-Santamaria J,Zhang A,et al。[(18)F]PS13的合成及其作为猴环氧合酶-1 PET放射性配体的评价。ACS化学神经科学。2021年;12: 517-30.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24:312–25.Article
Escartin C,Galea E,Lakatos A,O'Callaghan JP,Petzold GC,Serrano Pozo A等。反应性星形胶质细胞命名,定义和未来方向。Nat Neurosci。2021年;24:312–25.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Westlund KN, Denney RM, Kochersperger LM, Rose RM, Abell CW. Distinct monoamine oxidase A and B populations in primate brain. Science. 1985;230:181–3.Article
Westlund KN,Denney RM,Kochersperger LM,Rose RM,Abell CW。灵长类大脑中不同的单胺氧化酶A和B种群。科学。1985年;230:181–3.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Fowler JS, MacGregor RR, Wolf AP, Arnett CD, Dewey SL, Schlyer D, et al. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science. 1987;235:481–5.Article
Fowler JS,MacGregor RR,Wolf AP,Arnett CD,Dewey SL,Schlyer D等。用11C标记的自杀灭活剂和PET绘制人脑单胺氧化酶A和B。科学。1987年;235:481–5.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Fowler JS, Logan J, Volkow ND, Wang GJ, MacGregor RR, Ding YS. Monoamine oxidase: radiotracer development and human studies. Methods. 2002;27:263–77.Article
福勒JS,洛根J,沃尔科ND,王GJ,麦格雷戈RR,丁YS。单胺氧化酶:放射性示踪剂开发和人体研究。。2002年;27:263–77.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Fowler JS, Wang GJ, Logan J, Xie S, Volkow ND, MacGregor RR, et al. Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping. J Nucl Med. 1995;36:1255–62.CAS
。J Nucl Med。1995;36:1255-62.CAS
PubMed
PubMed
Google Scholar
谷歌学者
Kumlien E, Bergstrom M, Lilja A, Andersson J, Szekeres V, Westerberg CE, et al. Positron emission tomography with [11C]deuterium-deprenyl in temporal lobe epilepsy. Epilepsia. 1995;36:712–21.Article
Kumlien E,Bergstrom M,Lilja A,Andersson J,Szekeres V,Westerberg CE等。颞叶癫痫中[11 C]氘deprenyl的正电子发射断层扫描。。1995年;36:712-21.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Bergstrom M, Kumlien E, Lilja A, Tyrefors N, Westerberg G, Langstrom B. Temporal lobe epilepsy visualized with PET with 11C-L-deuterium-deprenyl-analysis of kinetic data. Acta Neurol Scand. 1998;98:224–31.Article
Bergstrom M,Kumlien E,Lilja A,Tyrefors N,Westerberg G,Langstrom B.用PET观察颞叶癫痫,并对动力学数据进行11C-L-氘-癸基分析。神经科学学报。1998年;
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kumlien E, Nilsson A, Hagberg G, Langstrom B, Bergstrom M. PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy. Acta Neurol Scand. 2001;103:360–6.Article
Kumlien E,Nilsson A,Hagberg G,Langstrom B,Bergstrom M.PET与11C氘deprenyl和18F-FDG在局灶性癫痫中的作用。神经科学学报。2001年;103:360–6.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Fowler JS, Volkow ND, Cilento R, Wang GJ, Felder C, Logan J. Comparison of brain glucose metabolism and monoamine oxidase B (MAO B) in traumatic brain injury. Clin Positron Imaging. 1999;2:71–79.Article
Fowler JS,Volkow ND,Cilento R,Wang GJ,Felder C,Logan J.创伤性脑损伤中脑葡萄糖代谢和单胺氧化酶B(MAO B)的比较。临床正电子成像。1999年;2: 71-79.文章
PubMed
PubMed
Google Scholar
谷歌学者
Ekblom J, Jossan SS, Gillberg PG, Oreland L, Aquilonius SM. Monoamine oxidase-B in motor cortex: changes in amyotrophic lateral sclerosis. Neuroscience. 1992;49:763–9.Article
Ekblom J,Jossan SS,Gillberg PG,Oreland L,Aquilonius SM。运动皮层中的单胺氧化酶-B:肌萎缩侧索硬化症的变化。神经科学。1992年;49:763–9.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Aquilonius SM, Jossan SS, Ekblom JG, Askmark H, Gillberg PG. Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography. J Neural Transm Gen Sect. 1992;89:111–22.Article
放射自显影显示,Aquilonius SM,Jossan SS,Ekblom JG,Askmark H,Gillberg PG.肌萎缩侧索硬化症患者脊髓中3H-L-癸酰基的结合增加。J Neural Transm Gen Sect。1992年;89:111-22.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Ekblom J, Jossan SS, Bergstrom M, Oreland L, Walum E, Aquilonius SM. Monoamine oxidase-B in astrocytes. Glia. 1993;8:122–32.Article
Ekblom J,Jossan SS,Bergstrom M,Oreland L,Walum E,Aquilonius SM。星形胶质细胞中的单胺氧化酶-B。。1993年;8: 122-32.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Johansson A, Engler H, Blomquist G, Scott B, Wall A, Aquilonius SM, et al. Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET. J Neurol Sci. 2007;255:17–22.Article
Johansson A,Engler H,Blomquist G,Scott B,Wall A,Aquilonius SM等[11C](L)-deprenyl-D2 PET证实ALS中星形细胞增多的证据。神经科学杂志。2007年;255:17–22.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Fowler JS, Volkow ND, Wang GJ, Logan J, Pappas N, Shea C, et al. Age-related increases in brain monoamine oxidase B in living healthy human subjects. Neurobiol Aging. 1997;18:431–5.Article
Fowler JS,Volkow ND,Wang GJ,Logan J,Pappas N,Shea C等。健康人类受试者大脑单胺氧化酶B的年龄相关增加。神经生物学老化。1997年;18: 431-5.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Arakawa R, Stenkrona P, Takano A, Nag S, Maior RS, Halldin C. Test-retest reproducibility of [(11)C]-L-deprenyl-D(2) binding to MAO-B in the human brain. EJNMMI Res. 2017;7:54.Article
Arakawa R,Stenkrona P,Takano A,Nag S,Maior RS,Halldin C.[(11)C]-L-癸酰基-D(2)与人脑中MAO-B结合的重测再现性。EJNMMI Res.2017;7: 54、条款
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Varnas K, Finnema SJ, Johnstrom P, Arakawa R, Halldin C, Eriksson LI, et al. Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo. Br J Anaesth. 2021;126:238–44.Article
Varnas K,Finnema SJ,Johnstrom P,Arakawa R,Halldin C,Eriksson LI等。七氟醚麻醉对体内放射性配体与单胺氧化酶-B结合的影响。Br J Anaesth公司。2021年;126:238-44.文章
PubMed
PubMed
Google Scholar
谷歌学者
Gulyas B, Pavlova E, Kasa P, Gulya K, Bakota L, Varszegi S, et al. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem Int. 2011;58:60–68.Article
Gulyas B,Pavlova E,Kasa P,Gulya K,Bakota L,Varszegi S等人在阿尔茨海默病患者的大脑中激活了MAO-B,通过使用全半球放射自显影的[11C]-L-癸酰基证明了这一点。Neurochem Int.2011;58:60–68.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kadir A, Marutle A, Gonzalez D, Scholl M, Almkvist O, Mousavi M, et al. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease. Brain. 2011;134:301–17.Article .
Kadir A,Marutle A,Gonzalez D,Scholl M,Almkvist O,Mousavi M等。第一位匹兹堡化合物B正电子发射断层扫描阿尔茨海默氏病患者的正电子发射断层扫描成像和与分子病理学相关的临床进展。大脑。2011年;134:301-17。第条。
PubMed
PubMed
Google Scholar
谷歌学者
Farid K, Carter SF, Rodriguez-Vieitez E, Almkvist O, Andersen P, Wall A, et al. Case report of complex amyotrophic lateral sclerosis with cognitive impairment and cortical amyloid deposition. J Alzheimers Dis. 2015;47:661–7.Article
Farid K,Carter SF,Rodriguez-Vieitez E,Almkvist O,Andersen P,Wall A等。伴有认知障碍和皮质淀粉样蛋白沉积的复杂肌萎缩侧索硬化症病例报告。阿尔茨海默病杂志。2015年;47:661–7.文章
PubMed
PubMed
Google Scholar
谷歌学者
Kumar A, Fontana IC, Nordberg A. Reactive astrogliosis: a friend or foe in the pathogenesis of Alzheimer’s disease. J Neurochem. 2023;164:309–24.Article
Kumar A,Fontana IC,Nordberg A.反应性星形胶质细胞增生:阿尔茨海默病发病机制中的朋友或敌人。神经化学杂志。2023年;164:309–24.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Santillo AF, Gambini JP, Lannfelt L, Langstrom B, Ulla-Marja L, Kilander L, et al. In vivo imaging of astrocytosis in Alzheimer’s disease: an (1)(1)C-L-deuteriodeprenyl and PIB PET study. Eur J Nucl Med Mol Imaging. 2011;38:2202–8.Article
Santillo AF,Gambini JP,Lannfelt L,Langstrom B,Ulla Marja L,Kilander L等。阿尔茨海默病星形细胞增多症的体内成像:一项(1)(1)C-L-氘代二烯基和PIB PET研究。Eur J Nucl Med Mol成像。2011年;38:2202–8.文章
PubMed
PubMed
Google Scholar
谷歌学者
Rodriguez-Vieitez E, Ni R, Gulyas B, Toth M, Haggkvist J, Halldin C, et al. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. Eur J Nucl Med Mol Imaging. 2015;42:1119–32.Article .
Rodriguez-Vieitez E,Ni R,Gulyas B,Toth M,Haggkwist J,Halldin C等。阿尔茨海默病APPswe转基因小鼠大脑中淀粉样斑块沉积之前的星形细胞增多:相关的正电子发射断层扫描和体外成像研究。Eur J Nucl Med Mol成像。2015年;42:1119-32。文章。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Carter SF, Scholl M, Almkvist O, Wall A, Engler H, Langstrom B, et al. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med. 2012;53:37–46.Article
Carter SF,Scholl M,Almkvist O,Wall A,Engler H,Langstrom B等。由11C-氘-L-癸基提供的前驱阿尔茨海默病星形细胞增多的证据:结合11C-匹兹堡化合物B和18F-FDG的多追踪PET范例。J Nucl Med。2012;53:37–46.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Choo IL, Carter SF, Scholl ML, Nordberg A. Astrocytosis measured by (1)(1)C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients. Eur J Nucl Med Mol Imaging. 2014;41:2120–6.Article
Choo IL,Carter SF,Scholl ML,Nordberg A.(1)(1)C-deprenyl PET测量的星形细胞增多与前驱阿尔茨海默病患者海马旁灰质密度的降低相关。Eur J Nucl Med Mol成像。2014年;41:2120–6.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Scholl M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, et al. Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography. Sci Rep. 2015;5:16404.Article
Scholl M,Carter SF,Westman E,Rodriguez-Vieitez E,Almkvist O,Thordardottir S等。通过多示踪剂正电子发射断层扫描在体内测量常染色体显性阿尔茨海默病的早期星形细胞增多症。Sci代表2015;5: 16404条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Scholl M, et al. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease. Brain. 2016;139:922–36.Article
Rodriguez-Vieitez E,Saint-Aubert L,Carter SF,Almkvist O,Farid K,Scholl M等。常染色体显性阿尔茨海默病星形细胞增多症和淀粉样蛋白PET的纵向变化。大脑。2016年;139:922–36.文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Carter SF, Chiotis K, Nordberg A, Rodriguez-Vieitez E. Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2019;46:348–56.Article
Carter SF,Chiotis K,Nordberg A,Rodriguez-Vieitez E.常染色体显性阿尔茨海默病中星形胶质细胞功能与葡萄糖代谢之间的纵向关联。Eur J Nucl Med Mol成像。;46:348-56.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Vilaplana E, Rodriguez-Vieitez E, Ferreira D, Montal V, Almkvist O, Wall A, et al. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease. Neurology. 2020;94:e2026–e2036.Article
Vilaplana E,Rodriguez-Vieitez E,Ferreira D,Montal V,Almkvist O,Wall A等。常染色体显性阿尔茨海默病星形细胞增多症的皮质微结构相关性。神经病学。2020年;94:e2026–e2036.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, et al. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer’s disease variants: AbetaPParc and PSEN1DE9. Mol Psychiatry. 2021;26:5609–19.Article
Lemoine L,Gillberg PG,Bogdanovic N,Nennesmo I,Saint-Aubert L,Viitanen M等。常染色体显性阿尔茨海默病变体中的淀粉样蛋白,tau和星形胶质细胞病理学:Abetaparc和PSEN1DE9。摩尔精神病学。2021年;26:5609–19.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Ni R, Rojdner J, Voytenko L, Dyrks T, Thiele A, Marutle A, et al. In vitro characterization of the regional binding distribution of amyloid PET tracer florbetaben and the glia tracers deprenyl and PK11195 in autopsy Alzheimer’s brain tissue. J Alzheimers Dis. 2021;80:1723–37.Article .
Ni R,Rojdner J,Voytenko L,Dyrks T,Thiele A,Marutle A等。尸检阿尔茨海默病脑组织中淀粉样蛋白PET示踪剂florbetaben和神经胶质示踪剂deprenyl和PK11195的区域结合分布的体外表征。阿尔茨海默病杂志。2021年;80:1723-37。文章。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I.et al. (3)H-deprenyl and (3)H-PIB autoradiography show different laminar distributions of astroglia and fibrillar beta-amyloid in Alzheimer brain. J Neuroinflammation. 2013;10:90.Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg PG, Nordberg A.
Marutle A,Gillberg PG,Bergfors A,Yu W,Ni R,Nennesmo I.et al。(3)H-deprenyl和(3)H-PIB放射自显影显示阿尔茨海默病大脑中星形胶质细胞和纤维状β-淀粉样蛋白的不同层状分布。J神经炎症。2013年;10: 90.Lemoine L,Saint-Aubert L,Nennesmo I,Gillberg PG,Nordberg A。
Cortical laminar tau deposits and activated astrocytes in Alzheimer’s disease visualised by (3)H-THK5117 and (3)H-deprenyl autoradiography. Sci Rep. 2017;7:45496.Article .
(3)H-THK5117和(3)H-deprenyl放射自显影显示阿尔茨海默病中的皮质层状tau沉积物和活化的星形胶质细胞。Sci代表2017;7: 第45496条。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Hirvonen J, Kailajarvi M, Haltia T, Koskimies S, Nagren K, Virsu P, et al. Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301. Clin Pharmacol Ther. 2009;85:506–12.Article
Hirvonen J,Kailajarvi M,Haltia T,Koskimies S,Nagren K,Virsu P等。用PET和[11C]-L-癸酰基-D2评估大脑中MAO-B的占有率:一种新型MAO-B抑制剂EVT 301的剂量发现研究。临床药理学。2009年;
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Sturm S, Forsberg A, Nave S, Stenkrona P, Seneca N, Varrone A, et al. Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline. Eur J Nucl Med Mol Imaging. 2017;44:382–91.Article .
Sturm S,Forsberg A,Nave S,Stenkrona P,Seneca N,Varrone A等。正电子发射断层扫描测量阿尔茨海默氏病患者和老年对照口服sembragiline后大脑MAO-B的抑制作用。Eur J Nucl Med Mol成像。2017年;44:382-91。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Nag S, Lehmann L, Heinrich T, Thiele A, Kettschau G, Nakao R, et al. Synthesis of three novel fluorine-18 labeled analogues of L-deprenyl for positron emission tomography (PET) studies of monoamine oxidase B (MAO-B). J Med Chem. 2011;54:7023–9.Article
Nag S,Lehmann L,Heinrich T,Thiele A,Kettschau G,Nakao R等。三种新型氟-18标记的L-癸酰基类似物的合成,用于单胺氧化酶B(MAO-B)的正电子发射断层扫描(PET)研究。J医学化学。2011年;54:7023–9.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Nag S, Varrone A, Toth M, Thiele A, Kettschau G, Heinrich T, et al. In vivo evaluation in cynomolgus monkey brain and metabolism of [(1)(8)F]fluorodeprenyl: a new MAO-B pet radioligand. Synapse. 2012;66:323–30.Article
Nag S,Varrone A,Toth M,Thiele A,Kettschau G,Heinrich T等。食蟹猴脑中的体内评估和[(1)(8)F]氟代癸基的代谢:一种新的MAO-B pet放射性配体。突触。2012年;66:323–30.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Nag S, Fazio P, Lehmann L, Kettschau G, Heinrich T, Thiele A, et al. In vivo and in vitro characterization of a novel MAO-B inhibitor radioligand, 18F-labeled deuterated fluorodeprenyl. J Nucl Med. 2016;57:315–20.Article
Nag S,Fazio P,Lehmann L,Kettschau G,Heinrich T,Thiele A等人。新型MAO-B抑制剂放射性配体18F标记的氘代氟代癸基的体内和体外表征。J Nucl Med。2016;57:315–20.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Ballweg A, Klaus C, Vogler L, Katzdobler S, Wind K, Zatcepin A.et al. (18)F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data. J Neuroinflammation. 2023;20:68.Vasdev N, Sadovski O, Moran MD, Parkes J, Meyer JH, Houle S, et al.
Ballweg A,Klaus C,Vogler L,Katzdobler S,Wind K,Zatcepin A.et al。(18)神经退行性疾病中反应性星形胶质细胞增生的F-DED PET成像:临床前概念验证和首次人类数据。J神经炎症。2023年;20: 68.Vasdev N,Sadovski O,Moran MD,Parkes J,Meyer JH,Houle S等。
Development of new radiopharmaceuticals for imaging monoamine oxidase B. Nucl Med Biol. 2011;38:933–43.Article .
。2011年;38:933-43。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Dukic-Stefanovic S, Hang Lai T, Toussaint M, Clauss O, Jevtic II, Penjisevic JZ, et al. In vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain. Bioorg Med Chem Lett. 2021;48:128254.Article .
Dukic Stefanovic S,Hang Lai T,Toussaint M,Clauss O,Jevtic II,Penjisevic JZ等。氟化茚满酮衍生物作为潜在正电子发射断层扫描剂的体内外评估,用于大脑中单胺氧化酶B的成像。Bioorg Med Chem Lett。2021年;。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Nag S, Lehmann L, Kettschau G, Heinrich T, Thiele A, Varrone A, et al. Synthesis and evaluation of [(1)(8)F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B). Bioorg Med Chem. 2012;20:3065–71.Article
Nag S,Lehmann L,Kettschau G,Heinrich T,Thiele A,Varrone A等。新型正电子发射断层扫描(PET)放射性配体单胺氧化酶B(MAO-B)的合成和评价。Bioorg医学化学。2012年;20: 3065-71.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Nag S, Lehmann L, Kettschau G, Toth M, Heinrich T, Thiele A, et al. Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B). Bioorg Med Chem. 2013;21:6634–41.Article
Nag S,Lehmann L,Kettschau G,Toth M,Heinrich T,Thiele A等。用于单氨基氧化酶B(MAO-B)PET研究的新型氟-18标记氘代氟雷沙吉兰([(18)F]氟雷沙吉兰-D2)放射性配体的开发。Bioorg医学化学。2013年;21:6634–41.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Harada R, Hayakawa Y, Ezura M, Lerdsirisuk P, Du Y, Ishikawa Y, et al. (18)F-SMBT-1: a selective and reversible PET tracer for monoamine oxidase-B imaging. J Nucl Med. 2021;62:253–8.Villemagne VL, Harada R, Dore V, Furumoto S, Mulligan R, Kudo Y, et al. First-in-humans evaluation of (18)F-SMBT-1, a Novel (18)F-labeled monoamine oxidase-B PET tracer for imaging reactive astrogliosis.
Harada R,Hayakawa Y,Ezura M,Lerdsirisuk P,Du Y,Ishikawa Y等。(18)F-SMBT-1:用于单胺氧化酶-B成像的选择性和可逆PET示踪剂。J Nucl Med。2021;62:253–8.Villemagne VL,Harada R,Dore V,Furumoto S,Mulligan R,Kudo Y等。首次在人类中评估(18)F-SMBT-1,一种新型(18)F标记的单胺氧化酶-B PET示踪剂,用于成像反应性星形胶质细胞增生。
J Nucl Med. 2022;63:1551–9.Article .
《核医学杂志》2022年;63:1551–9.文章[联合王国]。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Villemagne VL, Harada R, Dore V, Furumoto S, Mulligan R, Kudo Y, et al. Assessing reactive astrogliosis with (18)F-SMBT-1 across the Alzheimer disease spectrum. J Nucl Med. 2022;63:1560–9.Article
Villemagne VL,Harada R,Dore V,Furumoto S,Mulligan R,Kudo Y等。在阿尔茨海默病谱中用(18)F-SMBT-1评估反应性星形胶质细胞增生。J Nucl Med。2022;63:1560–9.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Olsen M, Aguilar X, Sehlin D, Fang XT, Antoni G, Erlandsson A, et al. Astroglial responses to amyloid-beta progression in a mouse model of Alzheimer’s disease. Mol Imaging Biol. 2018;20:605–14.Article
Olsen M,Aguilar X,Sehlin D,Fang XT,Antoni G,Erlandsson A等。阿尔茨海默病小鼠模型中星形胶质细胞对淀粉样β进展的反应。摩尔成像生物学。2018年;20: 605-14.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Chatterjee P, Dore V, Pedrini S, Krishnadas N, Thota R, Bourgeat P, et al. Plasma glial fibrillary acidic protein is associated with 18F-SMBT-1 PET: two putative astrocyte reactivity biomarkers for Alzheimer’s disease. J Alzheimers Dis. 2023;92:615–28.Article
。阿尔茨海默病杂志。2023年;92:615–28.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Dahl K, Bernard-Gauthier V, Nag S, Varnas K, Narayanaswami V, Mahdi Moein M, et al. Synthesis and preclinical evaluation of [(18)F]FSL25.1188, a reversible PET radioligand for monoamine oxidase-B. Bioorg Med Chem Lett. 2019;29:1624–7.Article
Dahl K,Bernard Gauthier V,Nag S,Varnas K,Narayanaswami V,Mahdi Moein M等。单胺氧化酶-B的可逆PET放射性配体[(18)F]FSL25.1188的合成和临床前评估。Bioorg Med Chem Lett。;29:1624-7.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Hicks JW, Sadovski O, Parkes J, Houle S, Hay BA, Carter RL, et al. Radiosynthesis and ex vivo evaluation of [(18)F]-(S)-3-(6-(3-fluoropropoxy)benzo[d]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one for imaging MAO-B with PET. Bioorg Med Chem Lett. 2015;25:288–91.Article
Hicks JW,Sadovski O,Parkes J,Houle S,Hay BA,Carter RL等,[(18)F]-(S)-3-(6-(3-氟丙氧基)苯并[d]异恶唑-3-基)-5-(甲氧基甲基)恶唑烷-2-酮的放射合成和离体评价,用于PET成像MAO-B。Bioorg Med Chem Lett。2015年;25:288–91.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Saba W, Valette H, Peyronneau MA, Bramoulle Y, Coulon C, Curet O, et al. (11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate. Synapse. 2010;64:61–69.Rusjan PM, Wilson AA, Miler L, Fan I, Mizrahi R, Houle S, et al.
Saba W,Valette H,Peyronneau MA,Bramoulle Y,Coulon C,Curet O等(11)C]SL25.1188,一种新的可逆放射性配体,用于研究PET的B型单胺氧化酶:非人灵长类动物的临床前表征。突触。2010年;64:61–69.Rusjan PM,Wilson AA,Miler L,Fan I,Mizrahi R,Houle S等。
Kinetic modeling of the monoamine oxidase B radioligand [(1)(1)C]SL25.1188 in human brain with high-resolution positron emission tomography. J Cereb Blood Flow Metab. 2014;34:883–9.Article .
用高分辨率正电子发射断层扫描对人脑中单胺氧化酶B放射性配体[(1)(1)C]SL25.1188进行动力学建模。。2014年;34:883-9。文章。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Moriguchi S, Wilson AA, Miler L, Rusjan PM, Vasdev N, Kish SJ, et al. Monoamine oxidase B total distribution volume in the prefrontal cortex of major depressive disorder: an [11C]SL25.1188 positron emission tomography study. JAMA Psychiatry. 2019;76:634–41.Article
Moriguchi S,Wilson AA,Miler L,Rusjan PM,Vasdev N,Kish SJ等。重性抑郁症前额叶皮层中单胺氧化酶B的总分布体积:一项[11C]SL25.1188正电子发射断层扫描研究。JAMA精神病学。;76:634-41.文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Gill T, Watling SE, Richardson JD, McCluskey T, Tong J, Meyer JH, et al. Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [(11)C]SL25.1188. Eur Neuropsychopharmacol. 2022;54:54–61.Article
Gill T,Watling SE,Richardson JD,McCluskey T,Tong J,Meyer JH等。创伤后应激障碍中星形胶质细胞的成像:单胺氧化酶B放射性配体[(11)C]SL25.1188的PET研究。Eur Neuropsychopharmacol。2022年;54:54–61.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Varnas K, Cselenyi Z, Arakawa R, Nag S, Stepanov V, Moein MM, et al. The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans. Neuropharmacology. 2020;162:107809.Article
。神经药理学。2020年;162:107809.文章
PubMed
PubMed
Google Scholar
谷歌学者
Koshimori Y, Cusimano MD, Vieira EL, Rusjan PM, Kish SJ, Vasdev N, et al. Astrogliosis marker 11C-SL25.1188 PET in traumatic brain injury with persistent symptoms. Brain. 2023;146:4469–75.Article
Koshimori Y,Cusimano MD,Vieira EL,Rusjan PM,Kish SJ,Vasdev N等。星形胶质细胞增生标记物11C-SL25.1188 PET在创伤性脑损伤中的持续症状。大脑。2023年;146:4469–75.文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Nag S, Jia Z, Svedberg M, Jackson A, Ahmad R, Luthra S, et al. Synthesis and autoradiography of novel F-18 labeled reversible radioligands for detection of monoamine oxidase B. ACS Chem Neurosci. 2020;11:4398–404.Article
Nag S,Jia Z,Svedberg M,Jackson A,Ahmad R,Luthra S等。用于检测单胺氧化酶B的新型F-18标记的可逆放射性配体的合成和放射自显影。ACS Chem Neurosci。2020年;11: 4398-404.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Varnas K, Nag S, Halldin C, Farde L. PET evaluation of the novel F-18 labeled reversible radioligand [(18)F]GEH200449 for detection of monoamine oxidase-B in the non-human primate brain. ACS Chem Neurosci. 2023;14:3206–11.Article
Varnas K,Nag S,Halldin C,Farde L.PET评估新型F-18标记的可逆放射性配体[(18)F]GEH200449,用于检测非人灵长类动物大脑中的单胺氧化酶-B。ACS化学神经科学。2023年;14: 3206–11.文章
PubMed
PubMed
Google Scholar
谷歌学者
Ruiz J, Martin I, Callado LF, Meana JJ, Barturen F, Garcia-Sevilla JA. Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer’s disease. Neurosci Lett. 1993;160:109–12.Article
鲁伊斯J,马丁I,卡拉多LF,梅纳JJ,巴图伦F,加西亚塞维利亚JA。阿尔茨海默病患者死后脑中非肾上腺素能受体[3H]咪唑啉结合位点(I2咪唑啉位点)增加。神经科学Lett。1993年;160:109–12.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Qiu WW, Zheng RY. Neuroprotective effects of receptor imidazoline 2 and its endogenous ligand agmatine. Neurosci Bull. 2006;22:187–91.CAS
邱伟伟,郑瑞。受体咪唑啉2及其内源性配体胍丁胺的神经保护作用。神经科学公牛。2006年;22:187–91.CAS
PubMed
PubMed
Google Scholar
谷歌学者
Hudson AL, Tyacke RJ, Lalies MD, Davies N, Finn DP, Marti O, et al. Novel ligands for the investigation of imidazoline receptors and their binding proteins. Ann N Y Acad Sci. 2003;1009:302–8.Article
Hudson AL,Tyacke RJ,Lalies MD,Davies N,Finn DP,Marti O等。用于研究咪唑啉受体及其结合蛋白的新型配体。Ann N Y Acad Sci。2003年;
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Saczewski F, Tabin P, Tyacke RJ, Maconie A, Saczewski J, Kornicka A, et al. 2-(4,5-dihydroimidazol-2-yl)benzimidazoles as highly selective imidazoline I2/adrenergic alpha2 receptor ligands. Bioorg Med Chem. 2006;14:6679–85.Article
Saczewski F,Tabin P,Tyacke RJ,Maconie A,Saczewski J,Kornicka A等2-(4,5-二氢咪唑-2-基)苯并咪唑作为高选择性咪唑啉I2/肾上腺素能α2受体配体。Bioorg医学化学。2006年;14: 6679–85.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Tyacke RJ, Fisher A, Robinson ES, Grundt P, Turner EM, Husbands SM, et al. Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline(2) binding site.
。
Synapse. 2012;66:542–51.Article .
突触。2012年;66:542-51。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kealey S, Turner EM, Husbands SM, Salinas CA, Jakobsen S, Tyacke RJ, et al. Imaging imidazoline-I2 binding sites in porcine brain using 11C-BU99008. J Nucl Med. 2013;54:139–44.Article
Kealey S,Turner EM,Hussons SM,Salinas CA,Jakobsen S,Tyacke RJ等。使用11C-BU99008对猪脑中的咪唑啉-I2结合位点进行成像。J Nucl Med。2013;54:139–44.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Parker CA, Nabulsi N, Holden D, Lin SF, Cass T, Labaree D, et al. Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain. J Nucl Med. 2014;55:838–44.Article
Parker CA,Nabulsi N,Holden D,Lin SF,Cass T,Labaree D等。恒河猴脑中咪唑啉2结合位点的PET配体11C-BU99008的评估。J Nucl Med。2014;55:838-44.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Tyacke RJ, Myers JFM, Venkataraman A, Mick I, Turton S, Passchier J, et al. Evaluation of (11)C-BU99008, a PET Ligand for the Imidazoline(2) Binding Site in Human Brain. J Nucl Med. 2018;59:1597–602.Article
Tyacke RJ,Myers JFM,Venkataraman A,Mick I,Turton S,Passchier J等。人脑中咪唑啉(2)结合位点的PET配体(11)C-BU99008的评估。J Nucl Med。2018;59:1597–602.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Venkataraman AV, Keat N, Myers JF, Turton S, Mick I, Gunn RN, et al. First evaluation of PET-based human biodistribution and radiation dosimetry of (11)C-BU99008, a tracer for imaging the imidazoline(2) binding site. EJNMMI Res. 2018;8:71.Article
Venkataraman AV,Keat N,Myers JF,Turton S,Mick I,Gunn RN等。首次评估基于PET的人体生物分布和(11)C-BU99008(一种用于成像咪唑啉(2)结合位点的示踪剂)的辐射剂量测定。EJNMMI Res.2018;8: 71、条款
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Kumar A, Koistinen NA, Malarte ML, Nennesmo I, Ingelsson M, Ghetti B, et al. Astroglial tracer BU99008 detects multiple binding sites in Alzheimer’s disease brain. Mol Psychiatry. 2021;26:5833–47.Article
Kumar A,Koistinen NA,Malarte ML,Nennesmo I,Ingelsson M,Ghetti B等。星形胶质细胞示踪剂BU99008检测阿尔茨海默病大脑中的多个结合位点。摩尔精神病学。2021年;26:5833–47.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Livingston NR, Calsolaro V, Hinz R, Nowell J, Raza S, Gentleman S, et al. Relationship between astrocyte reactivity, using novel (11)C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals. Mol Psychiatry. 2022;27:2019–29.Article .
Livingston NR,Calsolaro V,Hinz R,Nowell J,Raza S,Gentleman S等。使用新型(11)C-BU99008 PET的星形胶质细胞反应性与认知障碍个体的葡萄糖代谢,灰质体积和淀粉样蛋白负荷之间的关系。摩尔精神病学。2022年;27:2019-29。文章。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Calsolaro V, Matthews PM, Donat CK, Livingston NR, Femminella GD, Guedes SS, et al. Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using (11)C-BU99008 PET and its relationship with amyloid load. Mol Psychiatry. 2021;26:5848–55.Article
Calsolaro V,Matthews PM,Donat CK,Livingston NR,Femminella GD,Guedes SS等。使用(11)C-BU99008 PET在体内评估星形胶质细胞与迟发性认知障碍的反应性及其与淀粉样蛋白负荷的关系。摩尔精神病学。2021年;26:5848–55.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Wilson H, Dervenoulas G, Pagano G, Tyacke RJ, Polychronis S, Myers J, et al. Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study. Brain. 2019;142:3116–28.Article
Wilson H,Dervenoulas G,Pagano G,Tyacke RJ,Polychronis S,Myers J等。反映帕金森病星形胶质细胞病理学的咪唑啉2结合位点:体内11C-BU99008 PET研究。大脑。;142:3116–28.文章
PubMed
PubMed
Google Scholar
谷歌学者
Mohamed MA, Zeng Z, Gennaro M, Lao-Kaim NP, Myers JFM, Calsolaro V, et al. Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with (11)C-BU99008 PET. Brain Commun. 2022;4:fcac199.Article
Mohamed MA,Zeng Z,Gennaro M,Lao Kaim NP,Myers JFM,Calsolaro V等。衰老和帕金森氏病痴呆中的星形胶质细胞增生:一项使用(11)C-BU99008 PET的新临床研究。大脑通讯。2022年;4: fcac199.条款
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Kawamura K, Yui J, Konno F, Yamasaki T, Hatori A, Wakizaka H, et al. Synthesis and evaluation of PET probes for the imaging of I2 imidazoline receptors in peripheral tissues. Nucl Med Biol. 2012;39:89–99.Article
Kawamura K,Yui J,Konno F,Yamasaki T,Hatori A,Wakizaka H等。用于外周组织中I2咪唑啉受体成像的PET探针的合成和评估。Nucl医学生物学。2012年;39:89–99.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kawamura K, Kimura Y, Yui J, Wakizaka H, Yamasaki T, Hatori A, et al. PET study using [11C]FTIMD with ultra-high specific activity to evaluate I2-imidazoline receptors binding in rat brains. Nucl Med Biol. 2012;39:199–206.Article
Kawamura K,Kimura Y,Yui J,Wakizaka H,Yamasaki T,Hatori A等人使用具有超高比活性的[11C]FTIMD进行PET研究,以评估I2咪唑啉受体在大鼠大脑中的结合。Nucl医学生物学。2012年;39:199–206.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kawamura K, Naganawa M, Konno F, Yui J, Wakizaka H, Yamasaki T, et al. Imaging of I2-imidazoline receptors by small-animal PET using 2-(3-fluoro-[4-11C]tolyl)-4,5-dihydro-1H-imidazole ([11C]FTIMD). Nucl Med Biol. 2010;37:625–35.Kawamura K, Maeda J, Hatori A, Okauchi T, Nagai Y, Higuchi M, et al.
Kawamura K,Naganawa M,Konno F,Yui J,Wakizaka H,Yamasaki T等。使用2-(3-氟-[4-11C]甲苯基)-4,5-二氢-1H-咪唑([11C]FTIMD)通过小动物PET成像I2咪唑啉受体。Nucl医学生物学。2010年;37:625–35.Kawamura K,Maeda J,Hatori A,Okauchi T,Nagai Y,Higuchi M等。
In vivo and in vitro imaging of I(2) imidazoline receptors in the monkey brain. Synapse. 2011;65:452–5.Article .
猴脑中I(2)咪唑啉受体的体内和体外成像。突触。2011年;65:452-5条。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kawamura K, Shimoda Y, Kumata K, Fujinaga M, Yui J, Yamasaki T, et al. In vivo evaluation of a new (1)(8)F-labeled PET ligand, [(1)(8)F]FEBU, for the imaging of I(2)-imidazoline receptors. Nucl Med Biol. 2015;42:406–12.Article
Kawamura K,Shimoda Y,Kumata K,Fujinaga M,Yui J,Yamasaki T等。用于I(2)-咪唑啉受体成像的新(1)(8)F标记PET配体[(1)(8)F]FEBU的体内评估。Nucl医学生物学。2015年;42:406–12.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kawamura K, Yamasaki T, Zhang Y, Wakizaka H, Hatori A, Xie L, et al. Change in the Binding of [(11)C]BU99008 to imidazoline I2 receptor using brain PET in Zucker rats. Mol Imaging Biol. 2019;21:105–12.Article
Kawamura K,Yamasaki T,Zhang Y,Wakizaka H,Hatori A,Xie L等。Zucker大鼠使用脑PET改变[(11)C]BU99008与咪唑啉I2受体的结合。摩尔成像生物学。;21:105–12.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kawamura K, Shimoda Y, Yui J, Zhang Y, Yamasaki T, Wakizaka H, et al. A useful PET probe [(11)C]BU99008 with ultra-high specific radioactivity for small animal PET imaging of I(2)-imidazoline receptors in the hypothalamus. Nucl Med Biol. 2017;45:1–7.Article
Kawamura K,Shimoda Y,Yui J,Zhang Y,Yamasaki T,Wakizaka H等。一种有用的PET探针[(11)C]BU99008,具有超高比放射性,可用于下丘脑I(2)-咪唑啉受体的小动物PET成像。Nucl医学生物学。2017年;
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Brunt TM, Bossong MG. The neuropharmacology of cannabinoid receptor ligands in central signaling pathways. Eur J Neurosci. 2022;55:909–21.Article
Brunt TM,Bossong MG。中枢信号通路中大麻素受体配体的神经药理学。Eur J Neurosci。2022年;55:909–21.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Komorowska-Muller JA, Schmole AC. CB2 receptor in microglia: the guardian of self-control. Int J Mol Sci. 2020;22:19.Di Marzo V, Stella N, Zimmer A. Endocannabinoid signalling and the deteriorating brain. Nat Rev Neurosci. 2015;16:30–42.Article
Komorowska-Muller JA,Schmole AC.小胶质细胞中的CB2受体:自我控制的守护者。国际分子科学杂志。2020年;22:19.Di Marzo V,Stella N,Zimmer A.内源性大麻素信号传导和大脑恶化。Nat Rev Neurosci。2015年;16: 30-42.文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Grabon W, Bodennec J, Rheims S, Belmeguenai A, Bezin L. Update on the controversial identity of cells expressing cnr2 gene in the nervous system. CNS Neurosci Ther. 2023;29:760–70.Article
Grabon W,Bodennec J,Rheims S,Belmeguenai A,Bezin L.关于神经系统中表达cnr2基因的细胞的争议身份的最新信息。中枢神经系统神经科学。2023年;29:760–70.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Onaivi ES. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology. 2006;54:231–46.Article
大麻素CB2受体在大脑中的功能存在和表达的神经心理学证据。神经心理学。2006年;54:231–46.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310:329–32.Article
Van Sickle MD,Duncan M,Kingsley PJ,Mouihate A,Urbani P,Mackie K等。脑干大麻素CB2受体的鉴定和功能表征。科学。2005年;310:329–32.文章
PubMed
PubMed
Google Scholar
谷歌学者
Kibret BG, Ishiguro H, Horiuchi Y, Onaivi ES. New insights and potential therapeutic targeting of CB2 cannabinoid receptors in CNS disorders. Int J Mol Sci. 2022; 23.García-Gutiérrez MS, Navarrete F, Gasparyan A, Manzanares J. Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry.
Kibret BG,Ishiguro H,Horiuchi Y,Onaivi ES。CB2大麻素受体在中枢神经系统疾病中的新见解和潜在治疗靶向。国际分子科学杂志。2022年;23.García-Gutiérrez MS,Navarrete F,Gasparyan a,Manzanares J.大麻素受体2在神经精神病学中的治疗潜力。
Exploration of Neuroprotective Therapy 2021;1: 55–71.Evens N, Muccioli GG, Houbrechts N, Lambert DM, Verbruggen AM, Van Laere K, et al. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
探索神经保护疗法2021;1: 55-71.Evens N,Muccioli GG,Houbrechts N,Lambert DM,Verbruggen AM,Van Laere K等。用于2型大麻素受体正电子发射断层扫描成像的碳11和氟18标记的2-氧代喹啉衍生物的合成和生物学评估。
Nucl Med Biol. 2009;36:455–65.Article .
Nucl医学生物学。2009;36:455-65.文章[联合王国]。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Evens N, Vandeputte C, Coolen C, Janssen P, Sciot R, Baekelandt V, et al. Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer. Nucl Med Biol. 2012;39:389–99.Article
Evens N,Vandeputte C,Coolen C,Janssen P,Sciot R,Baekelandt V等。2型大麻素受体PET示踪剂[11C]NE40的临床前评估。Nucl医学生物学。2012年;39:389–99.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Vandeputte C, Casteels C, Struys T, Koole M, van Veghel D, Evens N, et al. Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model. Eur J Nucl Med Mol Imaging. 2012;39:1796–806.Article
Vandeputte C,Castels C,Struys T,Koole M,van Veghel D,Evens N等。光血栓形成中风模型中1型和2型大麻素受体的小动物PET成像。Eur J Nucl Med Mol成像。2012年;39:1796-806.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Ahmad R, Koole M, Evens N, Serdons K, Verbruggen A, Bormans G, et al. Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects. Mol Imaging Biol. 2013;15:384–90.Article
Ahmad R,Koole M,Evens N,Serdons K,Verbruggen A,Bormans G等。健康受试者中大麻素2型受体配体[11C]-NE40的全身生物分布和辐射剂量学。摩尔成像生物学。2013年;15: 384-90.文章
PubMed
PubMed
Google Scholar
谷歌学者
Hosoya T, Fukumoto D, Kakiuchi T, Nishiyama S, Yamamoto S, Ohba H, et al. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study. J Neuroinflammation. 2017;14:69.Article
Hosoya T,Fukumoto D,Kakiuchi T,Nishiyama S,Yamamoto S,Ohba H等。大鼠中风后神经炎症早期体内TSPO和大麻素受体2型的可用性:正电子发射断层扫描研究。J神经炎症。2017年;14: 69、条款
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Yamagishi S, Iga Y, Nakamura M, Takizawa C, Fukumoto D, Kakiuchi T, et al. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study. J Neuroinflammation. 2019;16:208.Article
Yamagishi S,Iga Y,Nakamura M,Takizawa C,Fukumoto D,Kakiuchi T等。衰老加速的小鼠神经炎症中大麻素受体2型而非TSPO的上调:正电子发射断层扫描研究。J神经炎症。;16: 第208条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Ahmad R, Postnov A, Bormans G, Versijpt J, Vandenbulcke M, Van Laere K. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2016;43:2219–27.Article
Ahmad R,Postnov A,Bormans G,Versijpt J,Vandenbulcke M,Van Laere K.降低了阿尔茨海默病中大麻素2型受体的体内可用性。Eur J Nucl Med Mol成像。2016年;43:2219–27.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Evens N, Bosier B, Lavey BJ, Kozlowski JA, Vermaelen P, Baudemprez L, et al. Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor. Nucl Med Biol. 2008;35:793–800.Article
Evens N,Bosier B,Lavey BJ,Kozlowski JA,Vermaelen P,Baudemprez L等人,[(11)C]甲氧基-Sch225336:大麻素2型受体的放射性配体的标记和生物学评价。Nucl医学生物学。2008年;35:793–800.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Vandeputte C, Evens N, Toelen J, Deroose CM, Bosier B, Ibrahimi A, et al. A PET brain reporter gene system based on type 2 cannabinoid receptors. J Nucl Med. 2011;52:1102–9.Article
Vandeputte C,Evens N,Toelen J,Deroose CM,Bosier B,Ibrahimi A等。基于2型大麻素受体的PET脑报告基因系统。J Nucl Med。2011;52:1102–9.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Ahamed M, van Veghel D, Ullmer C, Van Laere K, Verbruggen A, Bormans GM. Synthesis, biodistribution and in vitro evaluation of brain permeable high affinity type 2 cannabinoid receptor agonists [(11)C]MA2 and [(18)F]MA3. Front Neurosci. 2016;10:431.Article
Ahamed M,van Veghel D,Ullmer C,van Laere K,Verbruggen A,Bormans GM.脑渗透性高亲和力2型大麻素受体激动剂[(11)C]MA2和[(18)F]MA3的合成,生物分布和体外评估。前神经科学。2016年;10: 第431条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Evens N, Vandeputte C, Muccioli GG, Lambert DM, Baekelandt V, Verbruggen AM, et al. Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging. Bioorg Med Chem. 2011;19:4499–505.Article
Evens N,Vandeputte C,Muccioli GG,Lambert DM,Baekelandt V,Verbruggen AM等。氟-18标记的FE-GW405833作为2型大麻素受体成像的PET示踪剂的合成,体外和体内评估。Bioorg医学化学。2011年;19: 4499–505.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Horti AG, Gao Y, Ravert HT, Finley P, Valentine H, Wong DF, et al. Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2). Bioorg Med Chem. 2010;18:5202–7.Article
Horti AG,Gao Y,Ravert HT,Finley P,Valentine H,Wong DF等。大麻素2型受体(CB2)PET成像的新型潜在放射性配体[11C]A-836339的合成和生物分布。Bioorg医学化学。2010年;18: 5202–7.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Savonenko AV, Melnikova T, Wang Y, Ravert H, Gao Y, Koppel J, et al. Cannabinoid CB2 receptors in a mouse model of abeta amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation. PLoS One. 2015;10:e0129618.Article
Savonenko AV,Melnikova T,Wang Y,Ravert H,Gao Y,Koppel J等。abeta淀粉样变小鼠模型中的大麻素CB2受体:免疫组织化学分析和作为神经炎症PET生物标志物的适用性。PLoS One。2015年;10: e0129618。条款
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Pottier G, Gomez-Vallejo V, Padro D, Boisgard R, Dolle F, Llop J, et al. PET imaging of cannabinoid type 2 receptors with [(11)C]A-836339 did not evidence changes following neuroinflammation in rats. J Cereb Blood Flow Metab. 2017;37:1163–78.Article
Pottier G,Gomez-Vallejo V,Padro D,Boisgard R,Dolle F,Llop J等。用[(11)C]A-836339对大麻素2型受体进行PET成像未发现大鼠神经炎症后的变化。。2017年;37:1163-78.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Du Y, Coughlin JM, Brosnan MK, Chen A, Shinehouse LK, Abdallah R, et al. First-in-human imaging using [(11)C]MDTC: a radiotracer targeting the cannabinoid receptor type 2. Eur J Nucl Med Mol Imaging. 2023;50:2386–93.Article
Du Y,Coughlin JM,Brosnan MK,Chen A,Shinehouse LK,Abdallah R等。首次使用[(11)C]MDTC进行人体成像:靶向大麻素受体2型的放射性示踪剂。Eur J Nucl Med Mol成像。2023年;50:2386–93.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Fujinaga M, Kumata K, Yanamoto K, Kawamura K, Yamasaki T, Yui J, et al. Radiosynthesis of novel carbon-11-labeled triaryl ligands for cannabinoid-type 2 receptor. Bioorg Med Chem Lett. 2010;20:1565–8.Article
Fujinaga M,Kumata K,Yanamoto K,Kawamura K,Yamasaki T,Yui J等。大麻素2型受体新型碳11标记三芳基配体的放射合成。Bioorg Med Chem Lett。2010年;20: 1565-8.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Turkman N, Shavrin A, Paolillo V, Yeh HH, Flores L, Soghomonian S, et al. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor. Nucl Med Biol. 2012;39:593–600.Article
Turkman N,Shavrin A,Paolillo V,Yeh HH,Flores L,Soghomonian S等。用于大麻素CB2受体PET成像的[18F]标记的2-氧代喹啉衍生物的合成和初步评估。Nucl医学生物学。2012年;39:593–600.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Mu L, Bieri D, Slavik R, Drandarov K, Muller A, Cermak S, et al. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. J Neurochem. 2013;126:616–24.Article .
Mu L,Bieri D,Slavik R,Drandarov K,Muller A,Cermak S等。N-(1-金刚烷基)-8-甲氧基-4-氧代-1-苯基-1,4-二氢喹啉-3-甲酰胺作为大麻素2型受体成像的PET探针的放射性标记和体外/体内评估。神经化学杂志。2013年;126:616-24。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Lueg C, Schepmann D, Gunther R, Brust P, Wunsch B. Development of fluorinated CB(2) receptor agonists for PET studies. Bioorg Med Chem. 2013;21:7481–98.Article
Lueg C,Schepmann D,Gunther R,Brust P,Wunsch B.用于PET研究的氟化CB(2)受体激动剂的开发。Bioorg医学化学。2013年;21:7481–98.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Slavik R, Bieri D, Cermak S, Muller A, Kramer SD, Weber M, et al. Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain. Chimia (Aarau). 2014;68:208–10.Article
Slavik R,Bieri D,Cermak S,Muller A,Kramer SD,Weber M等。用于成像大脑中2型大麻素受体的新型PET示踪剂的开发和评估。Chimia(阿劳)。2014年;68:208–10.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Haider A, Muller Herde A, Slavik R, Weber M, Mugnaini C, Ligresti A, et al. Synthesis and biological evaluation of thiophene-based cannabinoid receptor type 2 radiotracers for PET imaging. Front Neurosci. 2016;10:350.Article
Haider A,Muller Herde A,Slavik R,Weber M,Mugnani C,Ligresti A等。用于PET成像的噻吩类大麻素受体2型放射性示踪剂的合成和生物学评估。前神经科学。2016年;10: 第350条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Slavik R, Muller Herde A, Haider A, Kramer SD, Weber M, Schibli R, et al. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2. J Neurochem. 2016;138:874–86.Article
Slavik R,Muller Herde A,Haider A,Kramer SD,Weber M,Schibli R等。发现氟化4-氧代喹啉衍生物作为潜在的正电子发射断层扫描放射性示踪剂,用于成像2型大麻素受体。神经化学杂志。2016年;138:874–86.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Haider A, Spinelli F, Herde AM, Mu B, Keller C, Margelisch M, et al. Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue. Eur J Med Chem. 2018;145:746–59.Article
Haider A,Spinelli F,Herde AM,Mu B,Keller C,Margelisch M等。R6/2舞蹈病亨廷顿小鼠模型和人ALS脊髓组织中基于4-氧代喹啉的CB2 PET放射性配体的评估。。2018年;145:746-59.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Haider A, Kretz J, Gobbi L, Ahmed H, Atz K, Burkler M, et al. Structure-activity relationship studies of pyridine-based ligands and identification of a fluorinated derivative for positron emission tomography imaging of cannabinoid type 2 receptors. J Med Chem. 2019;62:11165–81.Article .
Haider A,Kretz J,Gobbi L,Ahmed H,Atz K,Burkler M等。吡啶基配体的结构-活性关系研究和用于大麻素2型受体正电子发射断层扫描成像的氟化衍生物的鉴定。J医学化学。;62:11165-81。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kecheliev V, Spinelli F, Herde A, Haider A, Mu L, Klohs J, et al. Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease. Front Aging Neurosci. 2022;14:1018610.Article
Kecheliev V,Spinelli F,Herde A,Haider A,Mu L,Klohs J等。阿尔茨海默病小鼠模型大脑中大麻素2型受体表达和吡啶类放射性示踪剂的评估。前衰老神经科学。2022年;14: 第1018610条
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Ueberham L, Gundel D, Kellert M, Deuther-Conrad W, Ludwig FA, Lonnecke P, et al. Development of the high-affinity carborane-based cannabinoid receptor type 2 PET ligand [(18)F]LUZ5-d(8). J Med Chem. 2023;66:5242–60.Article
Ueberham L,Gundel D,Kellert M,Deuther Conrad W,Ludwig FA,Lonnecke P等。基于高亲和力碳硼烷的大麻素受体2型PET配体[(18)F]LUZ5-D(8)的开发。J医学化学。2023年;66:5242–60.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Kallinen A, Mardon K, Lane S, Montgomery AP, Bhalla R, Stimson DHR, et al. Synthesis and preclinical evaluation of fluorinated 5-azaindoles as CB2 PET radioligands. ACS Chem Neurosci. 2023;14:2902–21.Article
Kalline A,Mardon K,Lane S,Montgomery AP,Bhalla R,Stimson DHR等。氟化5-氮杂吲哚作为CB2 PET放射性配体的合成和临床前评估。ACS化学神经科学。2023年;14: 2902-21.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Pascali G, Panetta D, De Simone M, Burchielli S, Lucchesi V, Sanguinetti E, et al. Preliminary investigation of a novel 18F radiopharmaceutical for imaging CB2 Receptors in a SOD Mouse Model. Australian Journal of Chemistry. 2021;74:443–52.Article
Pascali G,Panetta D,De Simone M,Burchielli S,Lucchesi V,Sanguinetti E等。用于在SOD小鼠模型中成像CB2受体的新型18F放射性药物的初步研究。澳大利亚化学杂志。2021年;74:443–52.文章
CAS
中科院
Google Scholar
谷歌学者
Teodoro R, Gundel D, Deuther-Conrad W, Ueberham L, Toussaint M, Bormans G et al. Development of [(18)F]LU14 for PET imaging of cannabinoid receptor type 2 in the brain. Int J Mol Sci. 2021;22:8051.Gundel D, Deuther-Conrad W, Ueberham L, Kaur S, Otikova E, Teodoro R, et al. Structure-based design, optimization, and development of [(18)F]LU13: a novel radioligand for cannabinoid receptor type 2 imaging in the brain with PET.
Teodoro R,Gundel D,Deuther Conrad W,Ueberham L,Toussaint M,Bormans G等人开发了用于大脑中2型大麻素受体PET成像的[(18)F]LU14。国际分子科学杂志。2021年;22:8051.Gundel D,Deuther Conrad W,Ueberham L,Kaur S,Otikova E,Teodoro R等。基于结构的设计,优化和开发[(18)F]LU13:一种用于PET大脑中大麻素受体2型成像的新型放射性配体。
J Med Chem. 2022;65:9034–49.Article .
医学化学杂志。2022;65:9034–49.条款[联合王国]。
PubMed
PubMed
Google Scholar
谷歌学者
Slavik R, Herde AM, Bieri D, Weber M, Schibli R, Kramer SD, et al. Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor. Eur J Med Chem. 2015;92:554–64.Article
Slavik R,Herde AM,Bieri D,Weber M,Schibli R,Kramer SD等。新型4-氧代喹啉衍生物作为PET示踪剂用于大麻素2型受体成像的合成,放射性标记和评估。。2015年;92:554–64.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Slavik R, Grether U, Muller Herde A, Gobbi L, Fingerle J, Ullmer C, et al. Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor. J Med Chem. 2015;58:4266–77.Article
Slavik R,Grether U,Muller Herde A,Gobbi L,Fingerle J,Ullmer C等。发现高亲和力和选择性吡啶类似物作为大麻素2型受体的潜在正电子发射断层扫描成像剂。J医学化学。2015年;58:4266–77.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Moldovan RP, Teodoro R, Gao Y, Deuther-Conrad W, Kranz M, Wang Y, et al. Development of a high-affinity PET radioligand for imaging cannabinoid subtype 2 receptor. J Med Chem. 2016;59:7840–55.Article
摩尔多瓦RP,Teodoro R,Gao Y,Deuther Conrad W,Kranz M,Wang Y等。用于大麻素2型受体成像的高亲和力PET放射性配体的开发。J医学化学。2016年;59:7840–55.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Ni R, Muller Herde A, Haider A, Keller C, Louloudis G, Vaas M, et al. In vivo imaging of cannabinoid type 2 receptors: functional and structural alterations in mouse model of cerebral ischemia by PET and MRI. Mol Imaging Biol. 2022;24:700–9.Article
Ni R,Muller Herde A,Haider A,Keller C,Louloudis G,Vaas M等。大麻素2型受体的体内成像:通过PET和MRI在脑缺血小鼠模型中的功能和结构改变。Mol imaging Biol。2022年;
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Bravo GA, Cedeno RR, Casadevall MP, Ramio-Torrenta L. Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives. Cells. 2022; 11.McGinley MP, Cohen JA. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions.
Bravo GA,Cedeno RR,Casadevall MP,Ramio Torrenta L.鞘氨醇-1-磷酸(S1P)和S1P信号通路调节剂,从当前的见解到未来的观点。细胞。2022年;11.麦金利议员,科恩JA。多发性硬化症和其他疾病中的鞘氨醇1-磷酸受体调节剂。
Lancet. 2021;398:1184–94.Article .
柳叶刀。2021年;398:1184-94。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Chen H, Wang J, Zhang C, Ding P, Tian S, Chen J, et al. Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases. Biomed Pharmacother. 2022;153:113341.Article
陈浩,王杰,张超,丁平,田珊,陈杰,等。鞘氨醇1-磷酸受体,不同疾病治疗的新方向。Biomed Pharmacother。2022年;153:113341.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Brinkmann V. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol. 2009;158:1173–82.Article
Brinkmann V.FTY720(芬戈莫德)在多发性硬化症中的作用:对免疫和中枢神经系统的治疗作用。Br J药理学。2009年;158:1173-82.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Briard E, Orain D, Beerli C, Billich A, Streiff M, Bigaud M, et al. BZM055, an iodinated radiotracer candidate for PET and SPECT imaging of myelin and FTY720 brain distribution. ChemMedChem. 2011;6:667–77.Article
Briard E,Orain D,Beerli C,Billich A,Streiff M,Bigaud M等。BZM055是髓鞘和FTY720脑分布PET和SPECT成像的碘化放射性示踪剂候选物。化学药物化学。2011年;6: 667-77.条
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Rokka J, Federico C, Jurttila J, Snellman A, Haaparanta M, Rinne JO, et al. 19F/18F exchange synthesis for a novel [18F]S1P3-radiopharmaceutical. J Labelled Comp Radiopharm. 2013;56:385–91.Article
Rokka J,Federico C,Jurttila J,Snellman A,Haaparanta M,Rinne JO等。新型[18F]S1P3放射性药物的19F/18F交换合成。J标记的Comp Radiopharm。2013年;56:385–91.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Prasad VP, Wagner S, Keul P, Hermann S, Levkau B, Schafers M, et al. Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography. Bioorg Med Chem. 2014;22:5168–81.Article
Prasad VP,Wagner S,Keul P,Hermann S,Levkau B,Schafers M等。使用正电子发射断层扫描合成鞘氨醇-1-磷酸拮抗剂的氟化类似物作为分子成像的潜在放射性示踪剂。Bioorg医学化学。2014年;
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Briard E, Rudolph B, Desrayaud S, Krauser JA, Auberson YP. MS565: A SPECT tracer for evaluating the brain penetration of BAF312 (Siponimod). ChemMedChem. 2015;10:1008–18.Article
布莱德E,鲁道夫B,德斯雷奥S,克劳斯JA,奥伯森YP。MS565:用于评估BAF312(Siponimod)脑渗透的SPECT示踪剂。化学药物化学。2015年;10:
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Rosenberg AJ, Liu H, Tu Z. A practical process for the preparation of [(32)P]S1P and binding assay for S1P receptor ligands. Appl Radiat Isot. 2015;102:5–9.Article
Rosenberg AJ,Liu H,Tu Z.[(32)P]S1P的制备和S1P受体配体结合测定的实用方法。应用辐射等温线。2015年;102:5-9.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Liu H, Jin H, Yue X, Luo Z, Liu C, Rosenberg AJ, et al. PET imaging study of S1PR1 expression in a rat model of multiple sclerosis. Mol Imaging Biol. 2016;18:724–32.Article
Liu H,Jin H,Yue X,Luo Z,Liu C,Rosenberg AJ,等。多发性硬化大鼠模型中S1PR1表达的PET成像研究。摩尔成像生物学。2016年;18: 724-32.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Rosenberg AJ, Liu H, Jin H, Yue X, Riley S, Brown SJ, et al. Design, synthesis, and in vitro and in vivo evaluation of an (18)F-labeled sphingosine 1-phosphate receptor 1 (S1P1) PET Tracer. J Med Chem. 2016;59:6201–20.Article
Rosenberg AJ,Liu H,Jin H,Yue X,Riley S,Brown SJ等人(18)F标记的鞘氨醇1-磷酸受体1(S1P1)PET示踪剂的设计,合成以及体外和体内评估。J医学化学。2016年;59:6201–20.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Jin H, Yang H, Liu H, Zhang Y, Zhang X, Rosenberg AJ, et al. A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury. J Nucl Cardiol. 2017;24:558–70.Article
Jin H,Yang H,Liu H,Zhang Y,Zhang X,Rosenberg AJ等。一种有前途的碳-11标记的鞘氨醇-1-磷酸受体1特异性PET示踪剂,用于血管损伤成像。J Nucl Cardiol。2017年;
PubMed
PubMed
Google Scholar
谷歌学者
Liu H, Jin H, Yue X, Han J, Baum P, Abendschein DR, et al. PET study of sphingosine-1-phosphate receptor 1 expression in response to vascular inflammation in a rat model of carotid injury. Mol Imaging. 2017;16:1536012116689770.Article
Liu H,Jin H,Yue X,Han J,Baum P,Abendschein DR等。大鼠颈动脉损伤模型中鞘氨醇-1-磷酸受体1表达对血管炎症反应的PET研究。摩尔成像。2017年;16: 1536012116689770条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Liu H, Jin H, Han J, Yue X, Yang H, Zayed MA, et al. Upregulated sphingosine 1-phosphate receptor 1 expression in human and murine atherosclerotic plaques. Mol Imaging Biol. 2018;20:448–56.Article
Liu H,Jin H,Han J,Yue X,Yang H,Zayed MA等。上调人和鼠动脉粥样硬化斑块中鞘氨醇1-磷酸受体1的表达。摩尔成像生物学。2018年;20: 448-56.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Jiang H, Joshi S, Liu H, Mansor S, Qiu L, Zhao H, et al. In vitro and in vivo investigation of S1PR1 expression in the central nervous system using [(3)H]CS1P1 and [(11)C]CS1P1. ACS Chem Neurosci. 2021;12:3733–44.Article
Jiang H,Joshi S,Liu H,Mansor S,Qiu L,Zhao H,等。使用[(3)H]CS1P1和[(11)C]CS1P1体外和体内研究S1PR1在中枢神经系统中的表达。ACS化学神经科学。2021年;12: 3733-44.文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Chand GB, Jiang H, Miller JP, Rhodes CH, Tu Z, Wong DF. Differential sphingosine-1-phosphate receptor-1 protein expression in the dorsolateral prefrontal cortex between schizophrenia type 1 and type 2. Front Psychiatry. 2022;13:827981.Article
Chand GB,Jiang H,Miller JP,Rhodes CH,Tu Z,Wong DF。1型和2型精神分裂症患者背外侧前额叶皮层鞘氨醇-1-磷酸受体-1蛋白的差异表达。前沿精神病学。2022年;13: 827981条
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Liu H, Laforest R, Gu J, Luo Z, Jones LA, Gropler RJ, et al. Acute rodent tolerability, toxicity, and radiation dosimetry estimates of the S1P1-specific radioligand [(11)C]CS1P1. Mol Imaging Biol. 2020;22:285–92.Article
Liu H,Laforest R,Gu J,Luo Z,Jones LA,Gropler RJ等。S1P1特异性放射性配体[(11)C]CS1P1的急性啮齿动物耐受性,毒性和辐射剂量测定估计。摩尔成像生物学。2020年;22:285–92.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Luo Z, Gu J, Dennett RC, Gaehle GG, Perlmutter JS, Chen DL, et al. Automated production of a sphingosine-1 phosphate receptor 1 (S1P1) PET radiopharmaceutical [(11)C]CS1P1 for human use. Appl Radiat Isot. 2019;152:30–36.Article
Luo Z,Gu J,Dennett RC,Gaehle GG,Perlmutter JS,Chen DL等。人用鞘氨醇-1磷酸受体1(S1P1)PET放射性药物[(11)C]CS1P1的自动生产。应用辐射等温线。;152:30–36.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Brier MR, Hamdi M, Rajamanikam J, Zhao H, Mansor S, Jones LA, et al. Phase 1 evaluation of (11)C-CS1P1 to assess safety and dosimetry in human participants. J Nucl Med. 2022;63:1775–82.CAS
Brier MR,Hamdi M,Rajamanikam J,Zhao H,Mansor S,Jones LA等(11)C-CS1P1的第一阶段评估,以评估人类参与者的安全性和剂量学。J Nucl Med。2022;63:1775-82.CAS
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Qiu L, Jiang H, Yu Y, Gu J, Wang J, Zhao H, et al. Radiosynthesis and evaluation of a fluorine-18 radiotracer [(18)F]FS1P1 for imaging sphingosine-1-phosphate receptor 1. Org Biomol Chem. 2022;20:1041–52.Article
邱丽,姜红,余艳,顾杰,王杰,赵红,等。氟-18放射性示踪剂[(18)F]FS1P1的放射合成和评价,用于鞘氨醇-1-磷酸受体1的成像。组织Biomol Chem。2022年;20: 1041-52.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Liu H, Luo Z, Gu J, Jiang H, Joshi S, Shoghi KI, et al. In vivo characterization of four (18)F-labeled S1PR1 tracers for neuroinflammation. Mol Imaging Biol. 2020;22:1362–9.Article
Liu H,Luo Z,Gu J,Jiang H,Joshi S,Shoghi KI等。四(18)F标记的S1PR1神经炎症示踪剂的体内表征。摩尔成像生物学。2020年;22:1362–9.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Luo Z, Liu H, Yu Y, Gropler RJ, Klein RS, Tu Z. Synthesis and evaluation of highly selective quinazoline-2,4-dione ligands for sphingosine-1-phosphate receptor 2. RSC Med Chem. 2022;13:202–7.Article
Luo Z,Liu H,Yu Y,Gropler RJ,Klein RS,Tu Z.鞘氨醇-1-磷酸受体2的高选择性喹唑啉-2,4-二酮配体的合成和评价。RSC医学化学。2022年;13: 202-7.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Luo Z, Rosenberg AJ, Liu H, Han J, Tu Z. Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents. Eur J Med Chem. 2018;150:796–808.Article
Luo Z,Rosenberg AJ,Liu H,Han J,Tu Z.新S1PR1化合物的合成和体外评估以及啮齿动物中铅F-18放射性示踪剂的初步评估。。2018年;150:796-808.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Jiang H, Gu J, Zhao H, Joshi S, Perlmutter JS, Gropler RJ, et al. PET study of sphingosine-1-phosphate receptor 1 expression in response to S. aureus infection. Mol Imaging. 2021;2021:9982020.Article
Jiang H,Gu J,Zhao H,Joshi S,Perlmutter JS,Gropler RJ等。金黄色葡萄球菌感染后鞘氨醇-1-磷酸受体1表达的PET研究。摩尔成像。2021年;2021:9982020.文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Luo Z, Han J, Liu H, Rosenberg AJ, Chen DL, Gropler RJ, et al. Syntheses and in vitro biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates. Org Biomol Chem. 2018;16:9171–84.Article
Luo Z,Han J,Liu H,Rosenberg AJ,Chen DL,Gropler RJ等。S1PR1配体的合成和体外生物学评估以及非人灵长类动物大脑中四种F-18标记放射性示踪剂的PET研究。组织Biomol Chem。2018年;16: 9171-84.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Qiu L, Jiang H, Zhou C, Wang J, Yu Y, Zhao H, et al. Discovery of a promising fluorine-18 positron emission tomography radiotracer for imaging sphingosine-1-phosphate receptor 1 in the brain. J Med Chem. 2023;66:4671–88.Article
邱丽,姜红,周超,王杰,余艳,赵红,等。一种有前途的氟-18正电子发射断层显像放射性示踪剂的发现,用于脑内鞘氨醇-1-磷酸受体1的成像。J医学化学。2023年;66:4671–88.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Ye M, Gai Y, Ji H, Jiang Y, Qiao P, Wang W, et al. A novel radioimmune (99m)Tc-labeled tracer for imaging sphingosine 1-phosphate receptor 1 in tumor xenografts: an in vitro and in vivo study. Front Immunol. 2021;12:660842.Article
Ye M,Gai Y,Ji H,Jiang Y,Qiao P,Wang W,等。一种用于肿瘤异种移植物中鞘氨醇1-磷酸受体1成像的新型放射免疫(99m)Tc标记示踪剂:体外和体内研究。前免疫。2021年;12: 660842条
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Sehlin D, Syvanen S, Faculty M. Engineered antibodies: new possibilities for brain PET? Eur J Nucl Med Mol Imaging. 2019;46:2848–58.Article
Sehlin D,Syvanen S,Faculty M.工程抗体:脑PET的新可能性?Eur J Nucl Med Mol成像。;46:2848–58.文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Download referencesAcknowledgementsThis work was performed within the frameworks of LABEX PRIMES (ANR-11-LABX-0063, University of Lyon), the “Investissements d’Avenir” program (ANR-11-IDEX-0007, University of Lyon), the research program PURImaging (ANR-21-CE18-0067-01, University of Paris-Saclay, SHFJ-CEA Orsay), and the LABEX IRON (ANR-11-LABX-18-01, University of Tours) of the French National Research Agency (ANR).
下载参考文献致谢这项工作是在LABEX PRIMES(ANR-11-LABX-0063,里昂大学),“Avenir投资”计划(ANR-11-IDEX-0007,里昂大学),研究计划PURImaging(ANR-21-CE18-0067-01,巴黎萨克莱大学,SHFJ-CEA Orsay)和法国国家研究机构(ANR)的LABEX IRON(ANR-11-LABX-18-01,图尔大学)的框架内进行的。
GB was supported by the “Fondation ARC pour la recherche sur le cancer” through the “passerelle 2023” grant.Author informationAuthor notesGuillaume BeckerPresent address: Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, Cedex, FranceAuthors and AffiliationsUniversité Claude Bernard Lyon 1, Centre de Recherche en Neurosciences de Lyon, Inserm U1028, CNRS UMR5292, BIORAN, Groupement Hospitalier Est – CERMEP, 59 boulevard Pinel, 69677, Bron, Cedex, FranceFabien Chauveau & Guillaume BeckerUniversité Paris-Saclay, Inserm, CNRS, CEA, BioMaps, Service Hospitalier Frédéric Joliot, 4 place du général Leclerc, 91401, Orsay, FranceAlexandra WinkelerUMR 1253 iBrain, Université de Tours - INSERM, Bâtiment Planiol, UFR de Médecine, 10 Boulevard Tonnellé, 37032, Tours, Cedex 01, FranceSylvie Chalon & Hervé BoutinAuthorsFabien ChauveauView author publicationsYou can also search for this author in.
GB通过“Passelle 2023”赠款获得了“ARC癌症研究基金会”的支持。作者信息作者注Guillaume Beckerpresent地址:国家食品、环境和职业健康安全局,14 rue Pierre et Marie Curie,94701,Maisons Alfort,Cedex,FranceAuthors and AffiliationsUniversitéClaude Bernard Lyon 1,里昂神经科学研究中心,Inserm U1028,CNRS UMR5292,Bioran,Groupement Hospitalier Est–Cermep,59 Boulevard Pinel,69677,Bron,Cedex,Francefabien Chauveau&Guillaume BeckerUniversitéParis Saclay,Inserm,CNRS,CEA,生物地图,服务医院Frédéric Joliot,4 place du Général Leclerc,91401,Orsay,Franceaxandra Winkelerumr 1253 Ibrain,图尔本科Inserm,Bâtiment Planiol,医学院,10 boulevard Tonnellé,37032,图尔,Cedex 01,Francesylvie Chalon&HervéBoutinauthorsFabien Chauveauview作者出版物
PubMed Google ScholarAlexandra WinkelerView author publicationsYou can also search for this author in
PubMed Google ScholaralexandraWinkelerview作者出版物您也可以在
PubMed Google ScholarSylvie ChalonView author publicationsYou can also search for this author in
PubMed Google ScholarSylvie ChalonView作者出版物您也可以在
PubMed Google ScholarHervé BoutinView author publicationsYou can also search for this author in
PubMed Google ScholarHervéBoutinView作者出版物您也可以在
PubMed Google ScholarGuillaume BeckerView author publicationsYou can also search for this author in
PubMed Google ScholarGuillaume BeckerView作者出版物您也可以在
PubMed Google ScholarContributionsAll authors contributed equally to the writing of this review. HB coordinated and collated the contributions of all authors into the final manuscript. GB finalised the figures of this review; FC made the online interactive one (https://infogram.com/radar-spider-1h984wv3llqnd2p).Corresponding authorCorrespondence to.
PubMed谷歌学术贡献所有作者都为撰写这篇评论做出了同样的贡献。HB协调并将所有作者的贡献整理成最终手稿。GB最终确定了这次审查的数字;FC推出了在线互动(https://infogram.com/radar-spider-1h984wv3llqnd2p)。对应作者对应。
Hervé Boutin.Ethics declarations
HervéBoutin。道德宣言
Competing interests
相互竞争的利益
The authors declare no competing interests.
作者声明没有利益冲突。
Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Supplementary informationSupplementary materialRights and permissionsSpringer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.Reprints and permissionsAbout this articleCite this articleChauveau, F., Winkeler, A., Chalon, S.
Additional informationPublisher的注释Springer Nature在已发布的地图和机构隶属关系中的管辖权主张方面保持中立。补充信息补充材料权利和许可Pringer Nature或其许可方(例如协会或其他合作伙伴)根据与作者或其他权利持有人的出版协议对本文拥有独家权利;本文接受稿件版本的作者自行存档仅受此类出版协议和适用法律的条款管辖。。
et al. PET imaging of neuroinflammation: any credible alternatives to TSPO yet?..
等。神经炎症的PET成像:TSPO有可靠的替代品吗?。。
Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02656-9Download citationReceived: 19 December 2023Revised: 26 June 2024Accepted: 01 July 2024Published: 13 July 2024DOI: https://doi.org/10.1038/s41380-024-02656-9Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.
。https://doi.org/10.1038/s41380-024-02656-9Download引文接收日期:2023年12月19日修订日期:2024年6月26日接受日期:2024年7月1日发布日期:2024年7月13日OI:https://doi.org/10.1038/s41380-024-02656-9Share本文与您共享以下链接的任何人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享的链接。复制到剪贴板。
Provided by the Springer Nature SharedIt content-sharing initiative
由Springer Nature SharedIt内容共享计划提供